Kimberly-Clark (KMB) 10-K 8 Feb 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information Document - USD ($)	12 Months Ended
	Dec. 31, 2016	Feb. 01, 2017	Jun. 30, 2016
Entity Information [Line Items]
Entity Registrant Name	KIMBERLY CLARK CORP
Entity Central Index Key	55,785
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		356,274,872
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 49,500,000,000

Consolidated Income Statement

Consolidated Income Statement - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
Net Sales		$ 18,202	$ 18,591	$ 19,724
Cost of products sold		11,551	11,967	13,041
Gross Profit		6,651	6,624	6,683
Marketing, research and general expenses		3,326	3,443	3,709
Other (income) and expense, net	[1],[2]	8	1,568	453
Operating Profit		3,317	1,613	2,521
Interest income		11	17	18
Interest expense		(319)	(295)	(284)
Income From Continuing Operations Before Income Taxes and Equity Interests		3,009	1,335	2,255
Provision for income taxes		(922)	(418)	(856)
Income From Continuing Operations Before Equity Interests		2,087	917	1,399
Share of net income of equity companies		132	149	146
Income From Continuing Operations		2,219	1,066	1,545
Income from discontinued operations, net of income taxes		0	0	50
Net Income		2,219	1,066	1,595
Net income attributable to noncontrolling interests in continuing operations		(53)	(53)	(69)
Net Income Attributable to Kimberly-Clark Corporation		$ 2,166	$ 1,013	$ 1,526
Basic
Continuing operations		$ 6.03	$ 2.78	$ 3.94
Discontinued operations		0	0	0.13
Net income		6.03	2.78	4.07
Diluted
Continuing operations		5.99	2.77	3.91
Discontinued operations		0	0	0.13
Net income		5.99	2.77	4.04
Cash Dividends Declared		$ 3.68	$ 3.52	$ 3.36
[1]	Other (income) and expense, net for 2016 and 2015 includes income of $11 and a charge of $108, respectively, related to the deconsolidation of our Venezuelan operations, and for 2015 and 2014 includes charges of $40 and $421, respectively, related to the remeasurement of the Venezuelan balance sheet. In addition, 2015 includes $1,358 for charges related to pension settlements, and 2014 includes a charge of $35 related to a regulatory dispute in the Middle East.
[2]	Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.

Consolidated Statement of Compr

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 2,219	$ 1,066	$ 1,595
Other Comprehensive Income (Loss), Net of Tax
Unrealized currency translation adjustments	(107)	(922)	(835)
Employee postretirement benefits	(113)	942	(275)
Other	15	5	20
Total Other Comprehensive Income (Loss), Net of Tax	(205)	25	(1,090)
Comprehensive Income	2,014	1,091	505
Comprehensive income attributable to noncontrolling interests	(44)	(33)	(57)
Comprehensive Income Attributable to Kimberly-Clark Corporation	$ 1,970	$ 1,058	$ 448

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Current Assets
Cash and cash equivalents	$ 923	$ 619
Accounts receivable, net	2,176	2,281
Inventories	1,679	1,909
Other current assets	337	617
Total Current Assets	5,115	5,426
Property, Plant and Equipment, Net	7,169	7,104
Investments in Equity Companies	257	247
Goodwill	1,480	1,446
Other Assets	581	619
TOTAL ASSETS	14,602	14,842
Current Liabilities
Debt payable within one year	1,133	1,669
Trade accounts payable	2,609	2,612
Accrued expenses	1,775	1,750
Dividends payable	329	318
Total Current Liabilities	5,846	6,349
Long-Term Debt	6,439	6,106
Noncurrent Employee Benefits	1,301	1,137
Deferred Income Taxes	532	766
Other Liabilities	309	380
Redeemable Preferred Securities of Subsidiaries	58	64
Stockholders' Equity (Deficit)
Preferred stock - no par value - authorized 20.0 million shares, none issued	0	0
Common stock - $1.25 par value - authorized 1.2 billion shares; issued 378.6 million shares at December 31, 2016 and 2015	473	473
Additional paid-in capital	697	609
Common stock held in treasury, at cost - 22.0 and 17.7 million shares at December 31, 2016 and 2015, respectively	(3,629)	(2,972)
Retained earnings	5,831	4,994
Accumulated other comprehensive income (loss)	(3,474)	(3,278)
Total Kimberly-Clark Corporation Stockholders' Equity (Deficit)	(102)	(174)
Noncontrolling Interests	219	214
Total Stockholders' Equity	117	40
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 14,602	$ 14,842

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parenthetical) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0	$ 0
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 1.25	$ 1.25
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares issued	378,600,000	378,600,000
Common stock held in treasury, shares	22,029,000	17,737,000

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock Issued	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Noncontrolling Interests	Noncontrolling InterestsDividend Declared	Accumulated Other Comprehensive Income (Loss)
Treasury Stock, Value at Dec. 31, 2013				$ (3,746)
Common Stock, Value, Issued at Dec. 31, 2013		$ 536
Additional Paid in Capital at Dec. 31, 2013			$ 594
Retained Earnings (Accumulated Deficit) at Dec. 31, 2013					$ 9,714
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance at Dec. 31, 2013								$ (2,242)
Beginning Balance at Dec. 31, 2013						$ 284
Beginning Balance, treasury stock (in shares) at Dec. 31, 2013				47,798,000
Increase (Decrease) in Stockholders' Equity
Net income in stockholders' equity	$ 1,595				1,526
Net income in stockholders' equity, noncontrolling interests						39
Other comprehensive income, net of tax, attributable to parent	448							(1,078)
Other comprehensive income, net of tax, attributable to noncontrolling interest	(57)					(11)
Stock-based awards exercised or vested			(54)	$ 180
Stock-based awards exercised or vested (in shares)				(2,783,000)
Income tax benefits on stock-based compensation	19		32
Shares repurchased (in shares)				18,246,000
Shares repurchased				$ (2,031)
Recognition of stock-based compensation			52
Dividends declared					(1,256)
Spin-off of health care business					(1,505)			9
Dividends declared to noncontrolling interests							$ (43)
Other			8		(9)	1		(1)
Ending Balance (in shares) at Dec. 31, 2014		428,597,000
Ending Balance at Dec. 31, 2014						270
Ending Balance, treasury stock (in shares) at Dec. 31, 2014				63,261,000
Beginning Balance (in shares) at Dec. 31, 2013		428,597,000
Treasury Stock, Value at Dec. 31, 2014				$ (5,597)
Common Stock, Value, Issued at Dec. 31, 2014		$ 536
Additional Paid in Capital at Dec. 31, 2014			632
Retained Earnings (Accumulated Deficit) at Dec. 31, 2014					8,470
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance at Dec. 31, 2014								(3,312)
Increase (Decrease) in Stockholders' Equity
Net income in stockholders' equity	1,066				1,013
Net income in stockholders' equity, noncontrolling interests						48
Other comprehensive income, net of tax, attributable to parent	1,058							45
Other comprehensive income, net of tax, attributable to noncontrolling interest	(33)					(20)
Stock-based awards exercised or vested			(47)	$ 186
Stock-based awards exercised or vested (in shares)				(2,888,000)
Income tax benefits on stock-based compensation	29		32
Shares repurchased (in shares)				7,364,000
Shares repurchased				$ (833)
Recognition of stock-based compensation			75
Dividends declared					(1,280)
Dividends declared to noncontrolling interests							(36)
Shares purchased from noncontrolling interests, adjustments to additional paid in capital	(94)		(94)
Shares purchased from noncontrolling interests, decrease from purchase of noncontrolling interests								(12)
Shares purchased from noncontrolling interest						(45)
Other			11			(3)		1
Shares retired (shares)		(50,000,000)		(50,000,000)
Shares retired (amount)		$ (63)		$ 3,272	(3,209)
Ending Balance (in shares) at Dec. 31, 2015		378,597,000
Ending Balance at Dec. 31, 2015	$ 40					214
Ending Balance, treasury stock (in shares) at Dec. 31, 2015	17,737,000			17,737,000
Beginning Balance (in shares) at Dec. 31, 2014		428,597,000
Treasury Stock, Value at Dec. 31, 2015	$ 2,972			$ (2,972)
Common Stock, Value, Issued at Dec. 31, 2015	473	$ 473
Additional Paid in Capital at Dec. 31, 2015	609		609
Retained Earnings (Accumulated Deficit) at Dec. 31, 2015	4,994				4,994
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance at Dec. 31, 2015	(3,278)							(3,278)
Increase (Decrease) in Stockholders' Equity
Net income in stockholders' equity	2,219				2,166
Net income in stockholders' equity, noncontrolling interests						49
Other comprehensive income, net of tax, attributable to parent	1,970							(196)
Other comprehensive income, net of tax, attributable to noncontrolling interest	(44)					(8)
Stock-based awards exercised or vested			(14)	$ 121
Stock-based awards exercised or vested (in shares)				(1,906,000)
Income tax benefits on stock-based compensation	28		19
Shares repurchased (in shares)				6,198,000
Shares repurchased				$ (778)
Recognition of stock-based compensation			77
Dividends declared					(1,322)
Dividends declared to noncontrolling interests							$ (36)
Other			6		(7)
Ending Balance (in shares) at Dec. 31, 2016		378,597,000
Ending Balance at Dec. 31, 2016	$ 117					$ 219
Ending Balance, treasury stock (in shares) at Dec. 31, 2016	22,029,000			22,029,000
Beginning Balance (in shares) at Dec. 31, 2015		378,597,000
Treasury Stock, Value at Dec. 31, 2016	$ 3,629			$ (3,629)
Common Stock, Value, Issued at Dec. 31, 2016	473	$ 473
Additional Paid in Capital at Dec. 31, 2016	697		$ 697
Retained Earnings (Accumulated Deficit) at Dec. 31, 2016	5,831				$ 5,831
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance at Dec. 31, 2016	$ (3,474)							$ (3,474)

Consolidated Cash Flow Statemen

Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating Activities
Net income	$ 2,219	$ 1,066	$ 1,595
Depreciation and amortization	705	746	862
Stock-based compensation	77	75	52
Deferred income taxes	(15)	(255)	63
Equity companies' earnings (in excess of) less than dividends paid	(4)	(10)	28
Decrease (increase) in operating working capital	334	(445)	(176)
Pension and Other Postretirement Benefit Expense	(50)	930	(102)
Adjustments related to Venezuelan operations	(11)	153	462
Other	(23)	46	61
Cash Provided by Operations	3,232	2,306	2,845
Investing Activities
Capital spending	(771)	(1,056)	(1,039)
Proceeds from sales of investments	28	0	127
Investments in time deposits	(221)	(146)	(151)
Maturities of time deposits	188	164	239
Other	44	(12)	54
Cash Used for Investing	(732)	(1,050)	(770)
Financing Activities
Cash dividends paid	(1,311)	(1,272)	(1,256)
Change in short-term debt	(908)	303	721
Debt proceeds	1,293	1,100	1,257
Debt repayments	(598)	(553)	(123)
Redemption of redeemable preferred securities of subsidiary	0	0	(500)
Proceeds from exercise of stock options	107	140	127
Acquisitions of common stock for the treasury	(739)	(861)	(1,939)
Cash transferred to Halyard Health, Inc. related to spin-off	0	0	(120)
Shares purchased from noncontrolling interest	0	(151)	0
Other	(29)	(4)	(60)
Cash Used for Financing	(2,185)	(1,298)	(1,893)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(11)	(128)	(447)
Increase (Decrease) in Cash and Cash Equivalents	304	(170)	(265)
Cash and Cash Equivalents - Beginning of Year	619	789	1,054
Cash and Cash Equivalents - End of Year	$ 923	$ 619	$ 789

Accounting Policies

Accounting Policies	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Accounting Policies	Accounting Policies Basis of Presentation The consolidated financial statements present the accounts of Kimberly-Clark Corporation and all subsidiaries in which it has a controlling financial interest as if they were a single economic entity in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany transactions and accounts are eliminated in consolidation. The terms "Corporation," "Kimberly-Clark," "we," "our," and "us" refer to Kimberly-Clark Corporation and all subsidiaries in which it has a controlling financial interest. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted. In 2014, we completed the spin-off of our health care business, creating a stand-alone, publicly traded health care company, Halyard Health, Inc. ("Halyard"), by distributing 100 percent of the outstanding shares of Halyard to holders of our common stock. See Note 3 for more information. Accounting for Venezuelan Operations Effective December 31, 2015, we deconsolidated the assets and liabilities of our business in Venezuela from our consolidated balance sheet and moved to the cost method of accounting for our operations in that country. As of the first quarter of 2016, we no longer include the results of our Venezuelan business in our consolidated financial statements. The change resulted in the recognition of an after tax charge of $102 in 2015 and other income of $11 related to an updated assessment in 2016. In addition, we recorded a non-deductible charge of $45 and $462 in 2015 and 2014, respectively, related to a balance sheet remeasurement. Net sales of K-C Venezuela were insignificant in 2015 and 2014. Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, sales incentives and trade promotion allowances, employee postretirement benefits, and deferred income taxes and potential assessments. Cash Equivalents Cash equivalents are short-term investments with an original maturity date of three months or less. Inventories and Distribution Costs Most U.S. inventories are valued at the lower of cost, using the Last-In, First-Out ("LIFO") method, or market. The balance of the U.S. inventories and inventories of consolidated operations outside the U.S. are valued at the lower of cost and net realizable value using either the First-In, First-Out ("FIFO") or weighted-average cost methods. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Distribution costs are classified as cost of products sold. Property and Depreciation Property, plant and equipment are stated at cost and are depreciated on the straight-line method. Buildings are depreciated over their estimated useful lives, primarily 40 years . Machinery and equipment are depreciated over their estimated useful lives, primarily ranging from 16 to 20 years . Purchases of computer software, including external costs and certain internal costs (including payroll and payroll-related costs of employees) directly associated with developing significant computer software applications for internal use, are capitalized. Computer software costs are amortized on the straight-line method over the estimated useful life of the software, which generally does not exceed 5 years . Estimated useful lives are periodically reviewed and, when warranted, changes are made to them. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use and eventual disposition of an asset group, which are identifiable and largely independent of the cash flows of other asset groups, are less than the carrying amount of the asset group. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset group over its fair value. Fair value is measured using discounted cash flows or independent appraisals, as appropriate. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the consolidated balance sheet and any gain or loss on the transaction is included in income. Goodwill and Other Intangible Assets Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not amortized, but rather is assessed for impairment annually and whenever events and circumstances indicate that impairment may have occurred. Impairment testing compares the reporting unit carrying amount of goodwill with its fair value. If the reporting unit carrying amount of goodwill exceeds its fair value, an impairment charge would be recorded. In our evaluation of goodwill impairment, we have the option to first assess qualitative factors such as macroeconomic, industry and competitive conditions, legal and regulatory environment, historical and projected financial performance, significant changes in the reporting unit and the magnitude of excess fair value over carrying amount from the previous quantitative impairment testing. If the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative impairment test using discounted cash flows to estimate fair value must be performed. On the other hand, if the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is more than its carrying value, then further quantitative testing is not required. For 2016 , we completed the required annual assessment of goodwill for impairment for all of our reporting units using a qualitative assessment as of the first day of the third quarter, and determined that it is more likely than not that the fair value is more than the carrying amount for each of our reporting units. Intangible assets with finite lives are amortized over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Estimated useful lives range from 2 to 20 years for trademarks, 5 to 15 years for patents and developed technologies, and 5 to 15 years for other intangible assets. An impairment loss would be indicated when estimated undiscounted future cash flows from the use of the asset are less than its carrying amount. An impairment loss would be measured as the difference between the fair value (based on discounted future cash flows) and the carrying amount of the asset. Investments in Equity Companies Investments in companies which we do not control but over which we have the ability to exercise significant influence and that, in general, are at least 20 percent-owned by us, are stated at cost plus equity in undistributed net income. These investments are evaluated for impairment when warranted. An impairment loss would be recorded whenever a decline in value of an equity investment below its carrying amount is determined to be other than temporary. In judging "other than temporary," we would consider the length of time and extent to which the fair value of the equity company investment has been less than the carrying amount, the near-term and longer-term operating and financial prospects of the equity company, and our longer-term intent of retaining the investment in the equity company. Revenue Recognition Sales revenue is recognized at the time of product shipment or delivery, depending on when title passes, to unaffiliated customers, and when all of the following have occurred: a firm sales agreement is in place, pricing is fixed or determinable, and collection is reasonably assured. Sales are reported net of returns, consumer and trade promotions, rebates and freight allowed. Taxes imposed by governmental authorities on our revenue-producing activities with customers, such as sales taxes and value-added taxes, are excluded from net sales. Sales Incentives and Trade Promotion Allowances The cost of promotion activities provided to customers is classified as a reduction in sales revenue. In addition, the estimated redemption value of consumer coupons is recorded at the time the coupons are issued and classified as a reduction in sales revenue. Rebate and promotion accruals are based on estimates of the quantity of customer sales and the promotion accruals also consider estimates of the number of consumer coupons that will be redeemed and timing and costs of activities within the promotional programs. Advertising Expense Advertising costs are expensed in the year the related advertisement or campaign is first presented by the media. For interim reporting purposes, advertising expenses are charged to operations as a percentage of sales based on estimated sales and related advertising expense for the full year. Research Expense Research and development costs are charged to expense as incurred. Foreign Currency Translation The income statements of foreign operations, other than those in highly inflationary economies, are translated into U.S. dollars at rates of exchange in effect each month. The balance sheets of these operations are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in stockholders' equity as unrealized translation adjustments. Derivative Instruments and Hedging Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments, interest rate swaps and locks, and the majority of commodity hedging contracts are entered into with major financial institutions. At inception we formally designate certain derivatives as cash flow, fair value or net investment hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions or financial balances they are hedging. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings as they occur. All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The gain or loss on derivatives designated as fair value hedges and the offsetting loss or gain on the hedged item attributable to the hedged risk are included in income in the period that changes in fair value occur. The effective portion of the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. The gain or loss on derivatives designated as hedges of investments in foreign subsidiaries is recognized in other comprehensive income to offset the change in value of the net investments being hedged. Any ineffective portion of cash flow hedges and net investment hedges is immediately recognized in income. Certain foreign-currency derivative instruments not designated as hedging instruments have been entered into to manage a portion of our foreign currency transactional exposures. The gain or loss on these derivatives is included in income in the period that changes in their fair values occur. See Note 13 for disclosures about derivative instruments and hedging activities. New Accounting Standards In 2016, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842) . Under the new guidance, a lessee will be required to recognize assets and liabilities for all leases with lease terms of more than 12 months. Consistent with current GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily will depend on its classification as a finance or operating lease. The ASU requires additional disclosures. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. The ASU requires adoption based upon a modified retrospective transition approach. Early adoption is permitted. The effects of this standard on our financial position, results of operations and cash flows are not yet known. In 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718) . The new guidance simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public companies, the amendments in this standard are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The effects of this standard on our financial position, results of operations and cash flows are not expected to be material. In 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force) providing guidance on eight specific cash flow statement classification matters. The amendments in this standard are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The amendments in this standard should be applied using a retrospective transition method to each period presented. We will early adopt this ASU as of January 2017. The effects of this standard on our financial position, results of operations and cash flows are not expected to be material. In 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory , which removes the prohibition in ASC 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. The ASU is effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those annual periods. Early adoption is permitted for all entities as of the beginning of a fiscal year for which neither the annual or interim (if applicable) financial statements have been issued. The ASU should be applied on a modified retrospective basis, recognizing the effects in retained earnings as of the beginning of the year of adoption. The effects of this standard on our financial position, results of operations and cash flows are not yet known. In 2015, the FASB issued ASU No. 2015-07, Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) , which amends ASC 820, Fair Value Measurement . This ASU removes the requirement to categorize within the fair value hierarchy investments without readily determinable fair values in entities that elect to measure fair value using net asset value per share or its equivalent. The ASU requires that sufficient information be provided to permit reconciliation of the fair value of assets categorized within the fair value hierarchy to the amounts presented in the statement of financial position. We adopted this ASU in 2016 retrospectively. See Notes 5 and 9 for disclosure of investments that use net asset value per share or its equivalent to measure fair value. In 2015, the FASB issued ASU No. 2015-17, Income Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes . Under this ASU, a reporting entity is required to classify all deferred tax assets and liabilities as noncurrent in a classified balance sheet. Current guidance requiring the offsetting of deferred tax assets and liabilities of a tax-paying component of an entity and presentation as a single noncurrent amount is not affected. We early adopted this ASU prospectively and our 2016 consolidated balance sheet reflects the new guidance for classification of deferred taxes. Prior periods were not recasted. In 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers , which provides a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. In 2016, the FASB issued four amendments to the ASU. The standard is effective for public companies for annual and interim periods beginning after December 15, 2017. We will adopt this ASU effective January 1, 2018. The guidance is required to be adopted on either a full or modified retrospective basis. As this standard is not expected to have a material impact on our financial position, results of operations and cash flows on either a full or modified retrospective basis, we do not plan to recast prior periods.

2014 Organization Restructuring

2014 Organization Restructuring	12 Months Ended
	Dec. 31, 2016
2014 Organization Restructuring
Restructuring Cost and Reserve
2014 Organization Restructuring	2014 Organization Restructuring In 2014, we initiated a restructuring plan in order to improve organization efficiency and offset the impact of stranded overhead costs resulting from the spin-off of our health care business. The restructuring was intended to improve our underlying profitability and increase our flexibility to invest in targeted growth initiatives, brand building and other capabilities critical to delivering future growth. The restructuring impacted all of our business segments and our organizations in all major geographies. The restructuring actions were completed by December 31, 2016 , with total costs, primarily severance, of $164 after tax ( $231 pre-tax). Charges were recorded in the following income statement line items: Year Ended December 31 2016 2015 2014 Cost of products sold $ 6 $ 23 $ 40 Marketing, research and general expenses 32 40 93 Other (income) and expense, net (3 ) — — Provision for income taxes (8 ) (21 ) (38 ) Net charges $ 27 $ 42 $ 95 Cash payments of $60 and $86 were made during 2016 and 2015 , respectively.

Spinoff of Health Care Business

Spinoff of Health Care Business and Related Costs	12 Months Ended
	Dec. 31, 2016
Health Care Spin-off
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Spin-Off of Health Care Business and Related Costs	Spin-Off of Health Care Business and Related Costs On October 31, 2014, we completed the spin-off of our health care business, and each of our stockholders of record as of the close of business on October 23, 2014 (the "Record Date") received one share of Halyard common stock for every 8 shares of our common stock held as of the Record Date. The distribution was structured to be tax free to our U.S. stockholders for U.S. federal income tax purposes. After the distribution, we do not beneficially own any shares of Halyard common stock. To evaluate, plan and execute the spin-off, we incurred $157 of pre-tax charges ( $138 after tax) in transaction and related costs, including the exit of one of Halyard's health care glove manufacturing facilities in Thailand and outsourcing of the related production. These charges and the related tax impact are recorded in Income from discontinued operations, net of income taxes.

European Strategic Changes

European Strategic Changes	12 Months Ended
	Dec. 31, 2016
European Strategic Changes
Restructuring Cost and Reserve
Restructuring and Related Activities Disclosure	European Strategic Changes In 2012, we approved strategic changes related to our Western and Central European consumer and professional businesses to focus our resources and investments on stronger market positions and growth opportunities. Restructuring actions related to the strategic changes involved the sale or closure of five of our European manufacturing facilities and streamlining of our administrative organization. After tax charges of $30 were incurred in connection with the European strategic changes in 2014.

Fair Value Information

Fair Value Information	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Fair Value Information	Fair Value Information The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are: Level 1—Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities. Level 2—Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly. Level 3—Prices or valuations that require inputs that are significant to the valuation and are unobservable. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During 2016 and 2015 , there were no significant transfers among level 1, 2 or 3 fair value determinations. Company-owned life insurance ("COLI") assets and derivative assets and liabilities are measured on a recurring basis at fair value. COLI assets were $61 and $57 at December 31, 2016 and 2015 , respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in other assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy. At December 31, 2016 and 2015 , derivative assets were $43 and $56 , respectively, and derivative liabilities were $46 and $42 , respectively. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and NYMEX price quotations, respectively. The fair value of hedging instruments used to manage foreign currency risk is based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 13 . Redeemable preferred securities of subsidiaries are measured on a recurring basis at fair value and were $58 and $64 at December 31, 2016 and 2015, respectively. They are not traded in active markets. For certain redeemable securities, fair values were calculated using a floating rate pricing model that compared the stated spread to the fair value spread to determine the price at which each of the financial instruments should trade. The model used the following inputs to calculate fair values: face value, current LIBOR rate, unobservable fair value credit spread, stated spread, maturity date and interest or dividend payment dates. The fair value of the remaining redeemable securities was based on various inputs, including an independent third-party appraisal, adjusted for current market conditions. Measurement of the redeemable preferred securities is considered a level 3 measurement. The following table includes the fair value of our financial instruments for which disclosure of fair value is required: Fair Value Hierarchy Level Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value December 31, 2016 December 31, 2015 Assets Cash and cash equivalents (a) 1 $ 923 $ 923 $ 619 $ 619 Time deposits and other (b) 1 138 138 124 124 Liabilities Short-term debt (c) 2 170 170 1,071 1,071 Long-term debt (d) 2 7,402 7,886 6,704 7,300 (a) Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. (b) Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the consolidated balance sheet, as appropriate. Other, included in other current assets, is composed of funds held in escrow. Time deposits and other are recorded at cost, which approximates fair value. (c) Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. (d) Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets The changes in the carrying amount of goodwill by business segment are as follows: Personal Care Consumer Tissue K-C Professional Total Balance at December 31, 2014 $ 625 $ 594 $ 409 $ 1,628 Currency (92 ) (70 ) (20 ) (182 ) Balance at December 31, 2015 533 524 389 1,446 Currency 16 14 4 34 Balance at December 31, 2016 $ 549 $ 538 $ 393 $ 1,480 Intangible assets subject to amortization consist of the following at December 31: 2016 2015 Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Trademarks $ 108 $ 79 $ 109 $ 77 Patents and developed technologies 47 14 47 11 Other 58 37 60 34 Total $ 213 $ 130 $ 216 $ 122

Debt and Redeemable Preferred S

Debt and Redeemable Preferred Securities of Subsidiaries	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Debt and Redeemable Preferred Securities of Subsidiaries	Debt and Redeemable Preferred Securities of Subsidiaries Long-term debt is composed of the following: Weighted- Average Interest Rate Maturities December 31 2016 2015 Notes and debentures 4.3% 2017 - 2046 $ 7,101 $ 6,396 Industrial development revenue bonds 0.2% 2018 - 2045 264 264 Bank loans and other financings in various currencies 5.4% 2017 - 2028 37 44 Total long-term debt 7,402 6,704 Less current portion 963 598 Long-term portion $ 6,439 $ 6,106 Scheduled maturities of long-term debt for the next five years are $965 in 2017 , $936 in 2018 , $711 in 2019 , $757 in 2020 and $249 in 2021 . In July 2016 , we issued $500 aggregate principal amount of 3.20% notes due July 30, 2046 . Proceeds from the offering were used for general corporate purposes, including repayment of a portion of our outstanding commercial paper indebtedness. In February 2016 , we issued $400 aggregate principal amount of 1.40% notes due February 15, 2019 and $400 aggregate principal amount of 2.75% notes due February 15, 2026 . Proceeds from the offering were used for general corporate purposes, including repayment of a portion of our outstanding notes and commercial paper indebtedness. In August 2015 , we issued $250 aggregate principal amount of 2.15% notes due August 2020 and $300 aggregate principal amount of 3.05% notes due August 2025 . Proceeds from the offering were used to repay $300 of notes due in August 2015 and to pay down a portion of our outstanding commercial paper balance. In February 2015 , we issued $250 aggregate principal amount of 1.85% notes due March 2020 and $250 aggregate principal amount of 2.65% notes due March 2025 . Proceeds from the offering were used for general corporate purposes, including pension contribution payments. In 2015, at our election, we redeemed $200 of dealer remarketable securities. In October 2014 , we issued debt of $640 aggregate principal amount that was transferred to Halyard as part of the spin-off. In May 2014 , we issued $300 aggregate principal amount of floating rate notes due May 19, 2016 and $300 aggregate principal amount of 1.9% notes due May 22, 2019 . Proceeds from the offering were used for general corporate purposes and repurchases of common stock. We maintain a $2.0 billion revolving credit facility which expires in 2021 . This facility, currently unused, supports our commercial paper program, and would provide liquidity in the event our access to the commercial paper markets is unavailable for any reason. Redeemable Preferred Securities of Subsidiaries Our subsidiary in Central America has outstanding redeemable securities that are held by a noncontrolling interest and another noncontrolling interest holds certain redeemable preferred securities issued by one of our subsidiaries in North America. In December 2014, we redeemed $0.5 billion preferred securities in our Luxembourg-based financing subsidiary, and accordingly, the subsidiary became wholly-owned by Kimberly-Clark.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2016
Share-based Compensation [Abstract]
Stock-Based Compensation	Stock-Based Compensation We have a stock-based Equity Participation Plan and an Outside Directors' Compensation Plan (the "Plans"), under which we can grant stock options, restricted shares and restricted share units to employees and outside directors. As of December 31, 2016 , the number of shares of common stock available for grants under the Plans aggregated 18 million shares. Stock options are granted at an exercise price equal to the fair market value of our common stock on the date of grant, and they have a term of 10 years. Stock options are subject to graded vesting whereby options vest 30 percent at the end of each of the first two 12-month periods following the grant and 40 percent at the end of the third 12-month period. Restricted shares, time-vested restricted share units and performance-based restricted share units granted to employees are valued at the closing market price of our common stock on the grant date and vest generally at the end of three years. The number of performance-based share units that ultimately vest ranges from zero to 200 percent of the number granted, based on performance tied to return on invested capital ("ROIC") and net sales during the three-year performance period. ROIC and net sales targets are set at the beginning of the performance period. Restricted share units granted to outside directors are valued at the closing market price of our common stock on the grant date and vest when they are granted. The restricted period begins on the date of grant and expires on the date the outside director retires from or otherwise terminates service on our Board. At the time stock options are exercised or restricted shares and restricted share units become payable, common stock is issued from our accumulated treasury shares. Dividend equivalents are credited on restricted share units on the same date and at the same rate as dividends are paid on Kimberly-Clark's common stock. These dividend equivalents, net of estimated forfeitures, are charged to retained earnings. Stock-based compensation costs of $77 , $75 and $52 and related deferred income tax benefits of $28 , $29 and $19 were recognized for 2016 , 2015 and 2014 , respectively. The fair value of stock option awards was determined using a Black-Scholes-Merton option-pricing model utilizing a range of assumptions related to dividend yield, volatility, risk-free interest rate, and employee exercise behavior. Dividend yield is based on historical experience and expected future dividend actions. Expected volatility is based on a blend of historical volatility and implied volatility from traded options on Kimberly-Clark's common stock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. We estimate forfeitures based on historical data. The weighted-average fair value of options granted was estimated at $10.95 , $7.39 and $7.89 , in 2016 , 2015 and 2014 , respectively, per option on the date of grant based on the following assumptions: Year Ended December 31 2016 2015 2014 Dividend yield 3.1 % 3.5 % 3.5 % Volatility 16.0 % 13.4 % 13.4 % Risk-free interest rate 1.2 % 1.5 % 1.7 % Expected life - years 4.6 4.8 5.0 Total remaining unrecognized compensation costs and amortization period are as follows: December 31, 2016 Weighted-Average Service Years Nonvested stock options $ 10 1.4 Restricted shares and time-vested restricted share units 6 1.5 Nonvested performance-based restricted share units 53 1.8 Excess tax benefits, resulting from tax deductions in excess of the compensation cost recognized, aggregating $19 , $37 and $37 were classified as other cash inflows under Financing Activities in the consolidated cash flow statement for the years ended December 31, 2016 , 2015 and 2014 , respectively. A summary of stock-based compensation is presented below: Stock Options Shares (in thousands) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2016 6,590 $ 92.35 Granted 1,627 126.17 Exercised (1,249 ) 85.75 Forfeited or expired (175 ) 112.24 Outstanding at December 31, 2016 6,793 101.16 6.62 $ 107 Exercisable at December 31, 2016 3,667 86.87 4.86 $ 100 The total intrinsic value of options exercised during the years ended December 31, 2016 , 2015 and 2014 was $55 , $83 and $79 , respectively. Time-Vested Restricted Share Units Performance-Based Restricted Share Units Other Stock-Based Awards Shares (in thousands) Weighted- Average Grant-Date Fair Value Shares (in thousands) Weighted- Average Grant-Date Fair Value Nonvested at January 1, 2016 102 $ 108.91 1,761 $ 107.51 Granted 75 120.96 625 126.05 Vested (61 ) 107.17 (646 ) 101.17 Forfeited (5 ) 116.53 (98 ) 113.41 Nonvested at December 31, 2016 111 117.63 1,642 116.53 The total fair value of restricted share units that were distributed to participants during 2016 , 2015 and 2014 was $83 , $99 and $102 , respectively.

Employee Postretirement Benefit

Employee Postretirement Benefits	12 Months Ended
	Dec. 31, 2016
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Employee Postretirement Benefits	Employee Postretirement Benefits Substantially all regular employees in the U.S. and the United Kingdom are covered by defined benefit pension plans (the "Principal Plans") and/or defined contribution retirement plans. Certain other subsidiaries have defined benefit pension plans or, in certain countries, termination pay plans covering substantially all regular employees. The funding policy for our qualified defined benefit pension plans is to contribute assets at least equal in amount to regulatory minimum requirements. Nonqualified U.S. plans providing pension benefits in excess of limitations imposed by the U.S. income tax code are not funded. Substantially all U.S. retirees and employees have access to our unfunded healthcare and life insurance benefit plans. The annual increase in the consolidated weighted-average healthcare cost trend rate is expected to be 6.0 percent in 2017 and to decline to 4.6 percent in 2028 and thereafter. Assumed healthcare cost trend rates affect the amounts reported for postretirement healthcare benefit plans. A one-percentage-point change in assumed healthcare trend rates would not have a significant effect on our financial results. Effective January 2015, the U.S. pension plan was amended to include a lump-sum pension benefit payout option for certain plan participants. In addition, in April 2015, the U.S. pension plan completed the purchase of group annuity contracts that transferred to two insurance companies the pension benefit obligations totaling $2.5 billion for approximately 21,000 Kimberly-Clark retirees in the United States. As a result of these changes, we recognized pension settlement-related charges of $0.8 billion after tax ( $1.4 billion pre-tax in other (income) and expense, net) during 2015 , mostly in the second quarter. In 2015 , we made cash contributions of $410 related to these changes to the U.S. plan. Summarized financial information about postretirement plans, excluding defined contribution retirement plans, is presented below: Pension Benefits Other Benefits Year Ended December 31 2016 2015 2016 2015 Change in Benefit Obligation Benefit obligation at beginning of year $ 3,959 $ 6,860 $ 717 $ 788 Service cost 42 38 11 12 Interest cost 148 187 33 32 Actuarial loss (gain) 501 (150 ) 41 (53 ) Currency and other (304 ) (139 ) 9 (8 ) Benefit payments from plans (202 ) (235 ) — — Direct benefit payments (15 ) (12 ) (53 ) (54 ) Settlements (3 ) (2,590 ) — — Benefit obligation at end of year 4,126 3,959 758 717 Change in Plan Assets Fair value of plan assets at beginning of year 3,508 5,914 — — Actual return on plan assets 413 54 — — Employer contributions 108 484 — — Currency and other (290 ) (119 ) — — Benefit payments (202 ) (235 ) — — Settlements (3 ) (2,590 ) — — Fair value of plan assets at end of year 3,534 3,508 — — Funded Status $ (592 ) $ (451 ) $ (758 ) $ (717 ) Substantially all of the funded status of pension and other benefits is recognized in the consolidated balance sheet in noncurrent employee benefits, and the remainder is recognized in accrued expenses and other assets. Information for the Principal Plans and All Other Pension Plans Principal Plans All Other Pension Plans Total Year Ended December 31 2016 2015 2016 2015 2016 2015 Projected benefit obligation (“PBO”) $ 3,427 $ 3,295 $ 699 $ 664 $ 4,126 $ 3,959 Accumulated benefit obligation (“ABO”) 3,378 3,253 622 594 4,000 3,847 Fair value of plan assets 3,011 3,019 523 489 3,534 3,508 Approximately one-half of the PBO and fair value of plan assets for the Principal Plans relate to the U.S. qualified and nonqualified pension plans. Information for Pension Plans with an ABO in Excess of Plan Assets December 31 2016 2015 PBO $ 3,807 $ 2,115 ABO 3,736 2,096 Fair value of plan assets 3,243 1,696 Components of Net Periodic Benefit Cost Pension Benefits Other Benefits Year Ended December 31 2016 2015 2014 2016 2015 2014 Service cost $ 42 $ 38 $ 46 $ 11 $ 12 $ 13 Interest cost 148 187 279 33 32 35 Expected return on plan assets (a) (158 ) (215 ) (332 ) — — — Recognized net actuarial loss 52 75 100 — — — Settlements 1 1,357 20 — — — Other (9 ) (10 ) (3 ) (1 ) (1 ) (1 ) Net periodic benefit cost $ 76 $ 1,432 $ 110 $ 43 $ 43 $ 47 (a) The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return. Weighted-Average Assumptions Used to Determine Net Cost for Years Ended December 31 Pension Benefits Other Benefits Projected 2017 2016 2015 2014 2016 2015 2014 Discount rate 3.19 % 3.91 % 3.86 % 4.66 % 4.59 % 4.28 % 4.97 % Expected long-term return on plan assets 4.46 % 4.84 % 5.21 % 5.98 % — — — Rate of compensation increase 2.29 % 2.32 % 2.63 % 2.67 % — — — Weighted-Average Assumptions Used to Determine Benefit Obligations at December 31 Pension Benefits Other Benefits 2016 2015 2016 2015 Discount rate 3.19 % 3.91 % 4.29 % 4.59 % Rate of compensation increase 2.29 % 2.32 % — — Investment Strategies for the Principal Plans Strategic asset allocation decisions are made considering several risk factors, including plan participants' retirement benefit security, the estimated payments of the associated liabilities, the plan funded status, and Kimberly-Clark's financial condition. The resulting strategic asset allocation is a diversified blend of equity and fixed income investments. Equity investments are typically diversified across geographies and market capitalization. Fixed income investments are diversified across multiple sectors including government issues and corporate debt instruments with a portfolio duration that is consistent with the estimated payment of the associated liability. Actual asset allocation is regularly reviewed and periodically rebalanced to the strategic allocation when considered appropriate. Our 2017 target plan asset allocation for the Principal Plans is 70 percent fixed income securities and 30 percent equity securities. The expected long-term rate of return is evaluated on an annual basis. In setting this assumption, we consider a number of factors including projected future returns by asset class relative to the current asset allocation. The weighted-average expected long-term rate of return on pension fund assets used to calculate pension expense for the Principal Plans was 5.10 percent in 2016 compared with 5.35 percent in 2015 and will be 4.72 percent in 2017 . Set forth below are the pension plan assets of the Principal Plans measured at fair value, by level in the fair-value hierarchy. More than 90 percent of the assets are held in pooled funds and are measured using a net asset value (or its equivalent). Accordingly, such assets do not meet the Level 1, Level 2, or Level 3 criteria of the fair value hierarchy. Fair Value Measurements at December 31, 2016 Total Plan Assets Assets at Quoted Prices in Active Markets for Identical Assets (Level 1) Assets at Significant Observable Inputs (Level 2) Cash and Cash Equivalents Held directly $ 33 $ 33 $ — Held through mutual and pooled funds measured at net asset value 17 — — Fixed Income Held directly U.S. government and municipals 122 122 — Held through mutual and pooled funds measured at net asset value U.S. government and municipals 128 — — U.S. corporate debt 648 — — International bonds 1,223 — — Equity Held directly U.S. equity 41 41 — International equity 44 44 — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 68 — — Global equity 687 — — Total Plan Assets $ 3,011 $ 240 $ — For the U.S. pension plan, Treasury futures contracts are used when appropriate to manage duration targets. As of December 31, 2016 and December 31, 2015 , the U.S. plan had Treasury futures contracts in place with a total notional value of approximately $216 and $15 , respectively and an insignificant fair value. Fair Value Measurements at December 31, 2015 Total Plan Assets Assets at Quoted Prices in Active Markets for Identical Assets (Level 1) Assets at Significant Observable Inputs (Level 2) Cash and Cash Equivalents Held directly $ 14 $ 12 $ 2 Held through mutual and pooled funds measured at net asset value 34 — — Fixed Income Held directly U.S. government and municipals 157 141 16 U.S. corporate debt 21 — 21 Held through mutual and pooled funds measured at net asset value U.S. government and municipals 149 — — U.S. corporate debt 623 — — International bonds 1,236 — — Equity Held directly U.S. equity 58 58 — International equity 30 30 — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 67 — — Global equity 630 — — Total Plan Assets $ 3,019 $ 241 $ 39 During 2016 and 2015 , the plan assets did not include a significant amount of Kimberly-Clark common stock. Inputs and valuation techniques used to measure the fair value of plan assets vary according to the type of security being valued. Substantially all of the equity securities held directly by the plans are actively traded and fair values are determined based on quoted market prices. Fair values of U.S. Treasury securities are determined based on trading activity in the marketplace. Fair values of U.S. corporate debt, U.S. securitized fixed income and international bonds are typically determined by reference to the values of similar securities traded in the marketplace and current interest rate levels. Multiple pricing services are typically employed to assist in determining these valuations. Fair values of equity securities and fixed income securities held through units of pooled funds are based on net asset value of the units of the pooled fund determined by the fund manager. Pooled funds are similar in nature to retail mutual funds, but are typically more efficient for institutional investors. The fair value of pooled funds is determined by the value of the underlying assets held by the fund and the units outstanding. Equity securities held directly by the pension trusts and those held through units in pooled funds are monitored as to issuer and industry. Except for U.S. Treasuries, concentrations of fixed income securities are similarly monitored for concentrations by issuer and industry. As of December 31, 2016 , there were no significant concentrations of equity or debt securities in any single issuer or industry. We expect to contribute up to $100 to our defined benefit pension plans in 2017 . Over the next ten years, we expect that the following gross benefit payments will occur: Pension Benefits Other Benefits 2017 $ 225 $ 59 2018 242 59 2019 239 60 2020 247 61 2021 248 62 2022-2026 1,236 303 Defined Contribution Pension Plans Our 401(k) profit sharing plan and supplemental plan provide for a matching contribution of a U.S. employee's contributions and accruals, subject to predetermined limits, as well as a discretionary profit sharing contribution, in which contributions will be based on our profit performance. We also have defined contribution pension plans for certain employees outside the U.S. Costs charged to expense for our defined contribution pension plans were $126 , $107 and $121 in 2016 , 2015 and 2014 , respectively. Approximately one-third of these costs were for plans outside the U.S.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2016
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity During 2015 , we acquired the remaining 49.9 percent interest in our subsidiary in Israel, Hogla-Kimberly, Ltd., for $151 . As our subsidiary in Turkey was wholly-owned by our subsidiary in Israel, through this acquisition we also effectively acquired the remaining 49.9 percent interest in our subsidiary in Turkey, Kimberly-Clark Tuketim Mallari Sanayi ve Ticaret A.s. The purchase of additional ownership in an already controlled subsidiary is treated as an equity transaction with no gain or loss recognized in consolidated net income or comprehensive income. The effect of the change in ownership interest is as follows: 2015 Net Income Attributable to Kimberly-Clark Corporation $ 1,013 Decrease in Kimberly-Clark Corporation's additional paid-in capital for acquisition (94 ) Change from net income attributable to Kimberly-Clark Corporation and transfers to noncontrolling interests $ 919 Accumulated Other Comprehensive Income/Loss The changes in the components of accumulated other comprehensive income ("AOCI") attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2014 $ (1,335 ) $ (1,924 ) $ (37 ) $ (16 ) Other comprehensive income (loss) before reclassifications (942 ) 39 35 53 (Income) loss reclassified from AOCI 37 (a) 872 (b) (1 ) (b) (48 ) Net current period other comprehensive income (loss) (905 ) 911 34 5 Shares purchased from noncontrolling interests and other (12 ) — — 1 Balance as of December 31, 2015 (2,252 ) (1,013 ) (3 ) (10 ) Other comprehensive income (loss) before reclassifications (99 ) (115 ) (27 ) 33 (Income) loss reclassified from AOCI — 31 (b) (1 ) (b) (18 ) Net current period other comprehensive income (loss) (99 ) (84 ) (28 ) 15 Balance as of December 31, 2016 $ (2,351 ) $ (1,097 ) $ (31 ) $ 5 (a) Included in other (income) and expense, net as part of the charge related to the deconsolidation of our Venezuelan operations at December 31, 2015 (see Note 1 ). (b) Included in computation of net periodic pension and postretirement benefits costs (see Note 9 ). Included in the defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2016 is $1,162 and $34 of unrecognized net actuarial loss and unrecognized net prior service credit, respectively, of which $57 and $9 pre-tax, respectively, are expected to be recognized as a component of net periodic benefit cost in 2017 . The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2016 2015 2014 Unrealized translation $ (88 ) $ (882 ) $ (826 ) Tax effect (11 ) (23 ) 7 (99 ) (905 ) (819 ) Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (230 ) (4 ) (624 ) Amortization included in net periodic benefit cost 52 75 100 2015 U.S. plan settlements (recorded in Other (income) and expense, net) — 1,355 — Currency and other 81 42 69 (97 ) 1,468 (455 ) Unrecognized prior service cost/credit Funded status recognition (1 ) 4 42 Amortization included in net periodic benefit cost (8 ) (12 ) (7 ) Currency and other (6 ) (2 ) (3 ) (15 ) (10 ) 32 Tax effect 28 (547 ) 167 (84 ) 911 (256 ) Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other (45 ) 55 (36 ) Tax effect 17 (21 ) 14 (28 ) 34 (22 ) Cash flow hedges and other Recognition of effective portion of hedges 44 66 18 Amortization included in net income (20 ) (53 ) (5 ) Currency and other (4 ) (7 ) 2 Tax effect (5 ) (1 ) 3 15 5 18 Other — (11 ) 9 Change in AOCI $ (196 ) $ 34 $ (1,070 ) Amounts are reclassified from AOCI into cost of products sold, marketing, research and general expenses, interest expense or other (income) and expense, net, as applicable, in the consolidated income statement. Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2016 is primarily due to the weakening of most foreign currencies versus the U.S. dollar, including the British pound sterling, euro, and Korean won, partially offset by the strengthening of the Brazilian real. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Leases and Commitments

Leases and Commitments	12 Months Ended
	Dec. 31, 2016
Leases and Commitments
Leases and Commitments	Leases and Commitments We have entered into operating leases for certain warehouse facilities, automobiles and equipment. The future minimum obligations under operating leases having a noncancelable term in excess of one year are as follows: Year Ending December 31 2017 $ 187 2018 137 2019 94 2020 67 2021 39 Thereafter 73 Future minimum obligations $ 597 Consolidated rental expense under operating leases was $271 , $279 and $303 in 2016 , 2015 and 2014 , respectively. We have entered into long-term contracts for the purchase of superabsorbent materials, pulp and certain utilities. Commitments under these contracts based on current prices are $681 in 2017 , $184 in 2018 , $187 in 2019 , $197 in 2020 and beyond the year 2020 are not significant. Although we are primarily liable for payments on the above-mentioned leases and purchase commitments, our exposure to losses, if any, under these arrangements is not material.

Legal Matters

Legal Matters	12 Months Ended
	Dec. 31, 2016
Legal Matters
Legal Matters	Legal Matters We are subject to various legal proceedings, claims and governmental inquiries, inspections, audits or investigations pertaining to issues such as contract disputes, product liability, tax matters, patents and trademarks, advertising, pricing, business practices, governmental regulations, employment and other matters. Although the results of litigation and claims cannot be predicted with certainty, we believe that the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on our business, financial condition, results of operations or liquidity. We are subject to federal, state and local environmental protection laws and regulations with respect to our business operations and are operating in compliance with, or taking action aimed at ensuring compliance with, these laws and regulations. We have been named a potentially responsible party under the provisions of the U.S. federal Comprehensive Environmental Response, Compensation and Liability Act, or analogous state statutes, at a number of sites where hazardous substances are present. None of our compliance obligations with environmental protection laws and regulations, individually or in the aggregate, is expected to have a material adverse effect on our business, liquidity, financial condition or results of operations.

Objectives and Strategies for U

Objectives and Strategies for Using Derivatives	12 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Objectives and Strategies for Using Derivatives	Objectives and Strategies for Using Derivatives As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments. We enter into derivative instruments to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments. Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated and qualify as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt and those contracts are designated as cash flow hedges. We use derivative instruments, such as forward swap contracts, to hedge a limited portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowing. Translation exposure, which results from changes in translation rates between functional currencies and the U.S. dollar, generally is not hedged. Set forth below is a summary of the fair values of our derivative instruments: Assets Liabilities 2016 2015 2016 2015 Foreign currency exchange contracts $ 38 $ 56 $ 44 $ 27 Commodity price contracts 5 — 2 15 Total $ 43 $ 56 $ 46 $ 42 The derivative assets are included in the consolidated balance sheet in other current assets and other assets, as appropriate. The derivative liabilities are included in the consolidated balance sheet in accrued expenses and other liabilities, as appropriate. Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in current earnings. The offset to the change in fair values of the related hedged items also is recorded in current earnings. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to interest expense over the life of the related debt. At December 31, 2016 there were no outstanding interest rate contracts designated as fair value hedges. Fair value hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2016 , and gains or losses recognized in interest expense were not significant. For each of the three years ended December 31, 2016 , no gain or loss was recognized in earnings as a result of a hedged firm commitment no longer qualifying as a fair value hedge. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same period that the hedged exposure affects earnings. As of December 31, 2016 , outstanding commodity forward contracts were in place to hedge a limited portion of our estimated requirements of the related underlying commodities in 2017 and future periods. As of December 31, 2016 , the aggregate notional values of outstanding foreign exchange derivative contracts designated as cash flow hedges was $740 and there were no outstanding interest rate derivative contracts designated as cash flow hedges. Cash flow hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2016 , and no gains or losses were reclassified into earnings as a result of the discontinuance of cash flow hedges due to the original forecast transaction no longer being probable of occurring. At December 31, 2016 , amounts to be reclassified from AOCI during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at December 31, 2016 is January 2019 . Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in other (income) and expense, net. Losses of $30 , $188 and $192 were recorded in the years ending December 31, 2016 , 2015 and 2014 , respectively. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At December 31, 2016 , the notional amount of these undesignated derivative instruments was $1.9 billion .

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes An analysis of the provision for income taxes follows: Year Ended December 31 2016 2015 2014 Current income taxes United States $ 523 $ 223 $ 350 State 53 56 48 Other countries 361 394 387 Total 937 673 785 Deferred income taxes United States (40 ) (180 ) 67 State 31 (74 ) (16 ) Other countries (6 ) (1 ) 20 Total (15 ) (255 ) 71 Total provision for income taxes $ 922 $ 418 $ 856 Income from continuing operations before income taxes is earned in the following tax jurisdictions: Year Ended December 31 2016 2015 2014 United States $ 2,088 $ 451 $ 1,571 Other countries 921 884 684 Total income before income taxes $ 3,009 $ 1,335 $ 2,255 Deferred income tax assets and liabilities are composed of the following: December 31 2016 2015 Deferred tax assets Pension and other postretirement benefits $ 499 $ 682 Tax credits and loss carryforwards 450 443 Share based compensation 86 82 Other 512 517 1,547 1,724 Valuation allowances (225 ) (274 ) Total deferred tax assets 1,322 1,450 Deferred tax liabilities Pension and other postretirement benefits 15 254 Property, plant and equipment, net 1,079 1,118 Investments in subsidiaries 190 186 Goodwill 83 64 Other 253 217 Total deferred tax liabilities 1,620 1,839 Net deferred tax assets (liabilities) $ (298 ) $ (389 ) Valuation allowances at the end of 2016 primarily relate to tax credits, capital loss carryforwards, and income tax loss carryforwards of $0.7 billion . If these items are not utilized against taxable income, $473 of the income tax loss carryforwards will expire from 2017 through 2036 . The remaining $251 have no expiration date. Realization of income tax loss carryforwards is dependent on generating sufficient taxable income prior to expiration of these carryforwards. Although realization is not assured, we believe it is more likely than not that all of the deferred tax assets, net of applicable valuation allowances, will be realized. The amount of the deferred tax assets considered realizable could be reduced or increased due to changes in the tax environment or if estimates of future taxable income change during the carryforward period. Presented below is a reconciliation of the income tax provision computed at the U.S. federal statutory tax rate to the actual effective tax rate: Year Ended December 31 2016 2015 2014 U.S. statutory rate applied to income before income taxes 35.0 % 35.0 % 35.0 % Rate of state income taxes, net of federal tax benefit 1.8 (0.9 ) 0.7 Statutory rates other than U.S. statutory rate (2.7 ) (6.9 ) (3.0 ) Venezuela deconsolidation, balance sheet remeasurement and inflationary impacts (0.1 ) 4.5 4.9 Uncertain tax positions adjustment (a) — 3.7 — Routine tax incentives (4.0 ) (7.4 ) (3.6 ) Net tax cost on foreign income 0.1 5.1 3.6 Other - net (b) 0.5 (1.8 ) 0.4 Effective income tax rate 30.6 % 31.3 % 38.0 % (a) In 2015, we updated our assessment of uncertain tax positions for certain international operations and as a result we recorded an immaterial income tax charge of $49 related to prior years. (b) Other - net is composed of numerous items, none of which is greater than 1.75 percent of income before income taxes. At December 31, 2016 , U.S. income taxes and foreign withholding taxes have not been provided on $8.9 billion of unremitted earnings of subsidiaries operating outside the U.S. These earnings, which are considered to be invested indefinitely, would become subject to income tax if they were remitted as dividends, were lent to one of our U.S. entities, or if we were to sell our stock in the subsidiaries. Determination of the amount of unrecognized deferred U.S. income tax liability on these unremitted earnings is not practicable because of the complexities associated with this hypothetical calculation. We do not expect restrictions or taxes on repatriation of cash held outside of the U.S. to have a material effect on our overall liquidity, financial condition or results of operations in the foreseeable future. Presented below is a reconciliation of the beginning and ending amounts of unrecognized income tax benefits: 2016 2015 2014 Balance at January 1 $ 406 $ 416 $ 473 Gross increases for tax positions of prior years 20 80 36 Gross decreases for tax positions of prior years (104 ) (61 ) (91 ) Gross increases for tax positions of the current year 39 59 87 Settlements (29 ) (63 ) (77 ) Other (11 ) (25 ) (12 ) Balance at December 31 $ 321 $ 406 $ 416 Of the amounts recorded as unrecognized tax benefits at December 31, 2016 , $251 would reduce our effective tax rate if recognized. We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During each of the three years ended December 31, 2016 , the net impact in interest and penalties was not significant. Total accrued penalties and net accrued interest was $47 and $40 at December 31, 2016 and 2015 , respectively. It is reasonably possible that a number of uncertainties could be resolved within the next 12 months. The aggregate resolution of the uncertainties could be up to $140 , while none of the uncertainties is individually significant. Resolution of these matters is not expected to have a material effect on our financial condition, results of operations or liquidity. As of December 31, 2016 , the following tax years remain subject to examination for the major jurisdictions where we conduct business: Jurisdiction Years United States 2014 to 2016 United Kingdom 2012 to 2016 Brazil 2011 to 2016 Korea 2014 to 2016 China 2007 to 2016 Our U.S. federal income tax returns have been audited through 2013 . We have various federal income tax return positions in administrative appeals for 2004 , 2005 , 2007 and 2010 through 2013 . State income tax returns are generally subject to examination for a period of 3 to 5 years after filing of the respective return. The state effect of any changes to filed federal positions remains subject to examination by various states for a period of up to two years after formal notification to the states. We have various state income tax return positions in the process of examination, administrative appeals or litigation.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share ("EPS") There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows: (Millions of shares) 2016 2015 2014 Basic 359.4 363.8 374.5 Dilutive effect of stock options and restricted share unit awards 2.3 2.5 2.9 Diluted 361.7 366.3 377.4 Options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares were insignificant. The number of common shares outstanding as of December 31, 2016 , 2015 and 2014 was 356.6 million , 360.9 million and 365.3 million , respectively.

Description of Business Segment

Description of Business Segments	12 Months Ended
	Dec. 31, 2016
Segment Reporting [Abstract]
Business Segment Information	Business Segment Information We are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and KCP. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other (income) and expense, net and income and expense not associated with the business segments. The principal sources of revenue in each global business segment are described below: • Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise and other brand names. • Consumer Tissue offers a wide variety of innovative solutions and trusted brands that touch and improve people's lives every day. Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve and other brand names. • K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and Jackson Safety, are well-known for quality and trusted to help people around the world work better. Net sales to Wal-Mart Stores, Inc. were approximately 14 percent in 2016 and 2015 , and 13 percent in 2014 of our total net sales. Information concerning consolidated operations by business segment is presented in the following tables: Consolidated Operations by Business Segment Year Ended December 31 2016 2015 2014 NET SALES (a) Personal Care $ 9,046 $ 9,204 $ 9,635 Consumer Tissue 5,967 6,121 6,645 K-C Professional 3,150 3,219 3,388 Corporate & Other 39 47 56 TOTAL NET SALES $ 18,202 $ 18,591 $ 19,724 OPERATING PROFIT (b) Personal Care $ 1,857 $ 1,885 $ 1,803 Consumer Tissue 1,117 1,073 1,062 K-C Professional 603 590 604 Corporate & Other (c) (252 ) (367 ) (495 ) Other (income) and expense, net (d) 8 1,568 453 TOTAL OPERATING PROFIT $ 3,317 $ 1,613 $ 2,521 (a) Net sales in the United States to third parties totaled $8,874 , $8,819 and $8,573 in 2016 , 2015 and 2014 , respectively. (b) Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments. (c) Corporate & Other includes charges related to the 2014 Organization Restructuring of $38 , $63 and $133 in 2016, 2015 and 2014, respectively, and $5 and $41 related to the remeasurement of the Venezuelan balance sheet in 2015 and 2014 , respectively. Corporate & Other also includes charges of $23 for restructuring in Turkey in 2015 , and $33 related to European strategic changes in 2014 . (d) Other (income) and expense, net for 2016 and 2015 includes income of $11 and a charge of $108 , respectively, related to the deconsolidation of our Venezuelan operations, and for 2015 and 2014 includes charges of $40 and $421 , respectively, related to the remeasurement of the Venezuelan balance sheet. In addition, 2015 includes $1,358 for charges related to pension settlements, and 2014 includes a charge of $35 related to a regulatory dispute in the Middle East. Personal Care Consumer Tissue K-C Professional Corporate & Other Ongoing Operations Health Care Business (Spun-off) Consolidated Total Depreciation and Amortization 2016 $ 305 $ 280 $ 116 $ 4 $ 705 $ — $ 705 2015 340 282 121 3 746 — 746 2014 359 299 132 3 793 69 862 Assets 2016 6,141 4,761 2,151 1,549 14,602 — 14,602 2015 6,330 5,050 2,264 1,198 14,842 — 14,842 2014 6,373 5,229 2,339 1,585 15,526 — 15,526 Capital Spending 2016 421 250 95 5 771 — 771 2015 590 344 116 6 1,056 — 1,056 2014 501 314 143 6 964 75 1,039 Sales of Principal Products (Billions of dollars) 2016 2015 2014 Consumer tissue products $ 6.0 $ 6.1 $ 6.6 Baby and child care products 6.4 6.6 7.0 Away-from-home professional products 3.1 3.2 3.4 All other 2.7 2.7 2.7 Consolidated $ 18.2 $ 18.6 $ 19.7

Supplemental Data

Supplemental Data	12 Months Ended
	Dec. 31, 2016
Supplemental Data
Supplemental Data	Supplemental Data Supplemental Income Statement Data Year Ended December 31 2016 2015 2014 Advertising expense $ 665 $ 710 $ 767 Research expense 328 324 368 Equity Companies' Data Net Sales Gross Profit Operating Profit Net Income Corporation's Share of Net Income 2016 $ 2,138 $ 720 $ 454 $ 276 $ 132 2015 2,255 773 497 308 149 2014 2,452 781 485 304 146 Current Assets Non- Current Assets Current Liabilities Non- Current Liabilities Stockholders' Equity 2016 $ 963 $ 1,168 $ 531 $ 1,046 $ 554 2015 1,103 993 508 1,068 520 2014 1,016 1,040 690 963 403 Equity companies are principally engaged in operations in the personal care and consumer tissue businesses. At December 31, 2016 , our ownership interest in Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries was 47.9% . Kimberly-Clark de Mexico, S.A.B. de C.V. is partially owned by the public, and its stock is publicly traded in Mexico. At December 31, 2016 , our investment in this equity company was $188 , and the estimated fair value of the investment was $2.7 billion based on the market price of publicly traded shares. Our other equity ownership interests are not significant to our consolidated balance sheet or financial results. At December 31, 2016 , unremitted net income of equity companies included in consolidated retained earnings was $1.1 billion . Supplemental Balance Sheet Data December 31 Summary of Accounts Receivable, Net 2016 2015 From customers $ 2,077 $ 2,017 Other 167 329 Less allowance for doubtful accounts and sales discounts (68 ) (65 ) Total $ 2,176 $ 2,281 December 31 2016 2015 Summary of Inventories by Major Class LIFO Non- LIFO Total LIFO Non- LIFO Total Raw materials $ 93 $ 236 $ 329 $ 100 $ 297 $ 397 Work in process 114 89 203 110 93 203 Finished goods 430 600 1,030 525 689 1,214 Supplies and other — 280 280 — 278 278 637 1,205 1,842 735 1,357 2,092 Excess of FIFO or weighted-average cost over LIFO cost (163 ) — (163 ) (183 ) — (183 ) Total $ 474 $ 1,205 $ 1,679 $ 552 $ 1,357 $ 1,909 Inventories are valued at the lower of cost and net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method. December 31 Summary of Property, Plant and Equipment, Net 2016 2015 Land $ 163 $ 164 Buildings 2,612 2,537 Machinery and equipment 13,591 13,393 Construction in progress 488 453 16,854 16,547 Less accumulated depreciation (9,685 ) (9,443 ) Total $ 7,169 $ 7,104 Property, plant and equipment, net in the United States as of December 31, 2016 and 2015 was $3,638 and $3,716 , respectively. December 31 Summary of Accrued Expenses 2016 2015 Accrued advertising and promotion $ 373 $ 339 Accrued salaries and wages 426 392 Accrued rebates 220 229 Accrued taxes - income and other 259 329 Accrued interest 96 82 Derivatives 44 36 Other 357 343 Total $ 1,775 $ 1,750 Supplemental Cash Flow Statement Data Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital Year Ended December 31 2016 2015 2014 Accounts receivable $ (23 ) $ 60 $ 267 Inventories 230 (28 ) 12 Trade accounts payable (61 ) 44 (30 ) Accrued expenses 26 (110 ) (120 ) Accrued income taxes 121 (81 ) (159 ) Derivatives 43 (63 ) 103 Currency and other (2 ) (267 ) (249 ) Total $ 334 $ (445 ) $ (176 ) Year Ended December 31 Other Cash Flow Data 2016 2015 2014 Interest paid $ 315 $ 308 $ 300 Income taxes paid 744 695 926

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2016
Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	Description Balance at Beginning of Period Additions Deductions Charged to Costs and Expenses Charged to Other Accounts (a) Write-Offs and Reclassifications Balance at End of Period December 31, 2016 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 50 $ 8 $ 3 $ 11 (b) $ 50 Allowances for sales discounts 15 254 — 251 (c) 18 December 31, 2015 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 50 $ 12 $ (10 ) $ 2 (b) $ 50 Allowances for sales discounts 16 256 (1 ) 256 (c) 15 December 31, 2014 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 51 $ 13 $ (7 ) $ 7 (b) $ 50 Allowances for sales discounts 20 265 (1 ) 268 (c) 16 (a) Includes bad debt recoveries and the effects of changes in foreign currency exchange rates. (b) Primarily uncollectible receivables written off. (c) Sales discounts allowed. Additions Description Balance at Beginning of Period Charged to Costs and Expenses Charged to Other Accounts Deductions (a) Balance at End of Period December 31, 2016 Deferred taxes Valuation allowance $ 274 $ (45 ) $ — $ 4 $ 225 December 31, 2015 Deferred taxes Valuation allowance $ 215 $ 78 $ — $ 19 $ 274 December 31, 2014 Deferred taxes Valuation allowance $ 197 $ 30 $ — $ 12 $ 215 (a) Represents the net currency effects of translating valuation allowances at current rates of exchange.

Accounting Policies (Policy)

Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Accounting for Venezuelan Operations [Policy Text Block]	Accounting for Venezuelan Operations Effective December 31, 2015, we deconsolidated the assets and liabilities of our business in Venezuela from our consolidated balance sheet and moved to the cost method of accounting for our operations in that country. As of the first quarter of 2016, we no longer include the results of our Venezuelan business in our consolidated financial statements. The change resulted in the recognition of an after tax charge of $102 in 2015 and other income of $11 related to an updated assessment in 2016. In addition, we recorded a non-deductible charge of $45 and $462 in 2015 and 2014, respectively, related to a balance sheet remeasurement. Net sales of K-C Venezuela were insignificant in 2015 and 2014.
Use of Estimates	Use of Estimates The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, sales incentives and trade promotion allowances, employee postretirement benefits, and deferred income taxes and potential assessments.
Cash Equivalents	Cash Equivalents Cash equivalents are short-term investments with an original maturity date of three months or less.
Inventories and Distribution Costs	Inventories and Distribution Costs Most U.S. inventories are valued at the lower of cost, using the Last-In, First-Out ("LIFO") method, or market. The balance of the U.S. inventories and inventories of consolidated operations outside the U.S. are valued at the lower of cost and net realizable value using either the First-In, First-Out ("FIFO") or weighted-average cost methods. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Distribution costs are classified as cost of products sold.
Property and Depreciation	Property and Depreciation Property, plant and equipment are stated at cost and are depreciated on the straight-line method. Buildings are depreciated over their estimated useful lives, primarily 40 years . Machinery and equipment are depreciated over their estimated useful lives, primarily ranging from 16 to 20 years . Purchases of computer software, including external costs and certain internal costs (including payroll and payroll-related costs of employees) directly associated with developing significant computer software applications for internal use, are capitalized. Computer software costs are amortized on the straight-line method over the estimated useful life of the software, which generally does not exceed 5 years . Estimated useful lives are periodically reviewed and, when warranted, changes are made to them. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use and eventual disposition of an asset group, which are identifiable and largely independent of the cash flows of other asset groups, are less than the carrying amount of the asset group. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset group over its fair value. Fair value is measured using discounted cash flows or independent appraisals, as appropriate. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the consolidated balance sheet and any gain or loss on the transaction is included in income.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not amortized, but rather is assessed for impairment annually and whenever events and circumstances indicate that impairment may have occurred. Impairment testing compares the reporting unit carrying amount of goodwill with its fair value. If the reporting unit carrying amount of goodwill exceeds its fair value, an impairment charge would be recorded. In our evaluation of goodwill impairment, we have the option to first assess qualitative factors such as macroeconomic, industry and competitive conditions, legal and regulatory environment, historical and projected financial performance, significant changes in the reporting unit and the magnitude of excess fair value over carrying amount from the previous quantitative impairment testing. If the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative impairment test using discounted cash flows to estimate fair value must be performed. On the other hand, if the qualitative assessment determines that it is more likely than not that the fair value of a reporting unit is more than its carrying value, then further quantitative testing is not required. For 2016 , we completed the required annual assessment of goodwill for impairment for all of our reporting units using a qualitative assessment as of the first day of the third quarter, and determined that it is more likely than not that the fair value is more than the carrying amount for each of our reporting units. Intangible assets with finite lives are amortized over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Estimated useful lives range from 2 to 20 years for trademarks, 5 to 15 years for patents and developed technologies, and 5 to 15 years for other intangible assets. An impairment loss would be indicated when estimated undiscounted future cash flows from the use of the asset are less than its carrying amount. An impairment loss would be measured as the difference between the fair value (based on discounted future cash flows) and the carrying amount of the asset.
Investments in Equity Companies	Investments in Equity Companies Investments in companies which we do not control but over which we have the ability to exercise significant influence and that, in general, are at least 20 percent-owned by us, are stated at cost plus equity in undistributed net income. These investments are evaluated for impairment when warranted. An impairment loss would be recorded whenever a decline in value of an equity investment below its carrying amount is determined to be other than temporary. In judging "other than temporary," we would consider the length of time and extent to which the fair value of the equity company investment has been less than the carrying amount, the near-term and longer-term operating and financial prospects of the equity company, and our longer-term intent of retaining the investment in the equity company.
Revenue Recognition	Revenue Recognition Sales revenue is recognized at the time of product shipment or delivery, depending on when title passes, to unaffiliated customers, and when all of the following have occurred: a firm sales agreement is in place, pricing is fixed or determinable, and collection is reasonably assured. Sales are reported net of returns, consumer and trade promotions, rebates and freight allowed. Taxes imposed by governmental authorities on our revenue-producing activities with customers, such as sales taxes and value-added taxes, are excluded from net sales.
Sales Incentives and Trade Promotion Allowances	Sales Incentives and Trade Promotion Allowances The cost of promotion activities provided to customers is classified as a reduction in sales revenue. In addition, the estimated redemption value of consumer coupons is recorded at the time the coupons are issued and classified as a reduction in sales revenue. Rebate and promotion accruals are based on estimates of the quantity of customer sales and the promotion accruals also consider estimates of the number of consumer coupons that will be redeemed and timing and costs of activities within the promotional programs.
Advertising Expense	Advertising Expense Advertising costs are expensed in the year the related advertisement or campaign is first presented by the media. For interim reporting purposes, advertising expenses are charged to operations as a percentage of sales based on estimated sales and related advertising expense for the full year.
Research Expense	Research Expense Research and development costs are charged to expense as incurred.
Foreign Currency Translation	Foreign Currency Translation The income statements of foreign operations, other than those in highly inflationary economies, are translated into U.S. dollars at rates of exchange in effect each month. The balance sheets of these operations are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in stockholders' equity as unrealized translation adjustments.
Derivative Instruments and Hedging	Derivative Instruments and Hedging Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments, interest rate swaps and locks, and the majority of commodity hedging contracts are entered into with major financial institutions. At inception we formally designate certain derivatives as cash flow, fair value or net investment hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions or financial balances they are hedging. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings as they occur. All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The gain or loss on derivatives designated as fair value hedges and the offsetting loss or gain on the hedged item attributable to the hedged risk are included in income in the period that changes in fair value occur. The effective portion of the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. The gain or loss on derivatives designated as hedges of investments in foreign subsidiaries is recognized in other comprehensive income to offset the change in value of the net investments being hedged. Any ineffective portion of cash flow hedges and net investment hedges is immediately recognized in income. Certain foreign-currency derivative instruments not designated as hedging instruments have been entered into to manage a portion of our foreign currency transactional exposures. The gain or loss on these derivatives is included in income in the period that changes in their fair values occur.

2014 Organization Restructuri27

2014 Organization Restructuring (Tables)	12 Months Ended
	Dec. 31, 2016
2014 Organization Restructuring
Restructuring Cost and Reserve
Charges incurred in connection with restructuring	Charges were recorded in the following income statement line items: Year Ended December 31 2016 2015 2014 Cost of products sold $ 6 $ 23 $ 40 Marketing, research and general expenses 32 40 93 Other (income) and expense, net (3 ) — — Provision for income taxes (8 ) (21 ) (38 ) Net charges $ 27 $ 42 $ 95

Fair Value Information (Tables)

Fair Value Information (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Fair value of financial instruments	The following table includes the fair value of our financial instruments for which disclosure of fair value is required: Fair Value Hierarchy Level Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value December 31, 2016 December 31, 2015 Assets Cash and cash equivalents (a) 1 $ 923 $ 923 $ 619 $ 619 Time deposits and other (b) 1 138 138 124 124 Liabilities Short-term debt (c) 2 170 170 1,071 1,071 Long-term debt (d) 2 7,402 7,886 6,704 7,300 (a) Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. (b) Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the consolidated balance sheet, as appropriate. Other, included in other current assets, is composed of funds held in escrow. Time deposits and other are recorded at cost, which approximates fair value. (c) Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. (d) Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the carrying amount of goodwill	The changes in the carrying amount of goodwill by business segment are as follows: Personal Care Consumer Tissue K-C Professional Total Balance at December 31, 2014 $ 625 $ 594 $ 409 $ 1,628 Currency (92 ) (70 ) (20 ) (182 ) Balance at December 31, 2015 533 524 389 1,446 Currency 16 14 4 34 Balance at December 31, 2016 $ 549 $ 538 $ 393 $ 1,480
Intangible assets subject to amortization	Intangible assets subject to amortization consist of the following at December 31: 2016 2015 Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Trademarks $ 108 $ 79 $ 109 $ 77 Patents and developed technologies 47 14 47 11 Other 58 37 60 34 Total $ 213 $ 130 $ 216 $ 122

Debt and Reedemable Preferred S

Debt and Reedemable Preferred Securities of Subsidiaries (Tables)	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Long-term debt	Long-term debt is composed of the following: Weighted- Average Interest Rate Maturities December 31 2016 2015 Notes and debentures 4.3% 2017 - 2046 $ 7,101 $ 6,396 Industrial development revenue bonds 0.2% 2018 - 2045 264 264 Bank loans and other financings in various currencies 5.4% 2017 - 2028 37 44 Total long-term debt 7,402 6,704 Less current portion 963 598 Long-term portion $ 6,439 $ 6,106

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2016
Share-based Compensation [Abstract]
Schedule of weighted-average fair value of options, assumptions used	The weighted-average fair value of options granted was estimated at $10.95 , $7.39 and $7.89 , in 2016 , 2015 and 2014 , respectively, per option on the date of grant based on the following assumptions: Year Ended December 31 2016 2015 2014 Dividend yield 3.1 % 3.5 % 3.5 % Volatility 16.0 % 13.4 % 13.4 % Risk-free interest rate 1.2 % 1.5 % 1.7 % Expected life - years 4.6 4.8 5.0
Schedule of total remaining unrecognized compensation costs and amortization period	Total remaining unrecognized compensation costs and amortization period are as follows: December 31, 2016 Weighted-Average Service Years Nonvested stock options $ 10 1.4 Restricted shares and time-vested restricted share units 6 1.5 Nonvested performance-based restricted share units 53 1.8
Summary of stock-based compensation	A summary of stock-based compensation is presented below: Stock Options Shares (in thousands) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2016 6,590 $ 92.35 Granted 1,627 126.17 Exercised (1,249 ) 85.75 Forfeited or expired (175 ) 112.24 Outstanding at December 31, 2016 6,793 101.16 6.62 $ 107 Exercisable at December 31, 2016 3,667 86.87 4.86 $ 100
Summary of nonvested restricted share units	Time-Vested Restricted Share Units Performance-Based Restricted Share Units Other Stock-Based Awards Shares (in thousands) Weighted- Average Grant-Date Fair Value Shares (in thousands) Weighted- Average Grant-Date Fair Value Nonvested at January 1, 2016 102 $ 108.91 1,761 $ 107.51 Granted 75 120.96 625 126.05 Vested (61 ) 107.17 (646 ) 101.17 Forfeited (5 ) 116.53 (98 ) 113.41 Nonvested at December 31, 2016 111 117.63 1,642 116.53

Employee Postretirement Benef32

Employee Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2016
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]
Benefit Cost Information or Defined Benefit Plan and Other Postretirement Benefit Plan	Summarized financial information about postretirement plans, excluding defined contribution retirement plans, is presented below: Pension Benefits Other Benefits Year Ended December 31 2016 2015 2016 2015 Change in Benefit Obligation Benefit obligation at beginning of year $ 3,959 $ 6,860 $ 717 $ 788 Service cost 42 38 11 12 Interest cost 148 187 33 32 Actuarial loss (gain) 501 (150 ) 41 (53 ) Currency and other (304 ) (139 ) 9 (8 ) Benefit payments from plans (202 ) (235 ) — — Direct benefit payments (15 ) (12 ) (53 ) (54 ) Settlements (3 ) (2,590 ) — — Benefit obligation at end of year 4,126 3,959 758 717 Change in Plan Assets Fair value of plan assets at beginning of year 3,508 5,914 — — Actual return on plan assets 413 54 — — Employer contributions 108 484 — — Currency and other (290 ) (119 ) — — Benefit payments (202 ) (235 ) — — Settlements (3 ) (2,590 ) — — Fair value of plan assets at end of year 3,534 3,508 — — Funded Status $ (592 ) $ (451 ) $ (758 ) $ (717 )
Principal Plans and all Other Pension Plans	Information for the Principal Plans and All Other Pension Plans Principal Plans All Other Pension Plans Total Year Ended December 31 2016 2015 2016 2015 2016 2015 Projected benefit obligation (“PBO”) $ 3,427 $ 3,295 $ 699 $ 664 $ 4,126 $ 3,959 Accumulated benefit obligation (“ABO”) 3,378 3,253 622 594 4,000 3,847 Fair value of plan assets 3,011 3,019 523 489 3,534 3,508
Pension Plans with an ABO in Excess of Plan Assets	Information for Pension Plans with an ABO in Excess of Plan Assets December 31 2016 2015 PBO $ 3,807 $ 2,115 ABO 3,736 2,096 Fair value of plan assets 3,243 1,696
Components of Net Periodic Benefit Cost	Components of Net Periodic Benefit Cost Pension Benefits Other Benefits Year Ended December 31 2016 2015 2014 2016 2015 2014 Service cost $ 42 $ 38 $ 46 $ 11 $ 12 $ 13 Interest cost 148 187 279 33 32 35 Expected return on plan assets (a) (158 ) (215 ) (332 ) — — — Recognized net actuarial loss 52 75 100 — — — Settlements 1 1,357 20 — — — Other (9 ) (10 ) (3 ) (1 ) (1 ) (1 ) Net periodic benefit cost $ 76 $ 1,432 $ 110 $ 43 $ 43 $ 47 (a) The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.
Weighted-Average Assumptions Used to Determine Net Cost	Weighted-Average Assumptions Used to Determine Net Cost for Years Ended December 31 Pension Benefits Other Benefits Projected 2017 2016 2015 2014 2016 2015 2014 Discount rate 3.19 % 3.91 % 3.86 % 4.66 % 4.59 % 4.28 % 4.97 % Expected long-term return on plan assets 4.46 % 4.84 % 5.21 % 5.98 % — — — Rate of compensation increase 2.29 % 2.32 % 2.63 % 2.67 % — — —
Weighted-Average Assumptions Used to Determine Benefit Obligations	Weighted-Average Assumptions Used to Determine Benefit Obligations at December 31 Pension Benefits Other Benefits 2016 2015 2016 2015 Discount rate 3.19 % 3.91 % 4.29 % 4.59 % Rate of compensation increase 2.29 % 2.32 % — —
Pension Plan Assets of the Principal Plans Measured at Fair Value	Fair Value Measurements at December 31, 2016 Total Plan Assets Assets at Quoted Prices in Active Markets for Identical Assets (Level 1) Assets at Significant Observable Inputs (Level 2) Cash and Cash Equivalents Held directly $ 33 $ 33 $ — Held through mutual and pooled funds measured at net asset value 17 — — Fixed Income Held directly U.S. government and municipals 122 122 — Held through mutual and pooled funds measured at net asset value U.S. government and municipals 128 — — U.S. corporate debt 648 — — International bonds 1,223 — — Equity Held directly U.S. equity 41 41 — International equity 44 44 — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 68 — — Global equity 687 — — Total Plan Assets $ 3,011 $ 240 $ — For the U.S. pension plan, Treasury futures contracts are used when appropriate to manage duration targets. As of December 31, 2016 and December 31, 2015 , the U.S. plan had Treasury futures contracts in place with a total notional value of approximately $216 and $15 , respectively and an insignificant fair value. Fair Value Measurements at December 31, 2015 Total Plan Assets Assets at Quoted Prices in Active Markets for Identical Assets (Level 1) Assets at Significant Observable Inputs (Level 2) Cash and Cash Equivalents Held directly $ 14 $ 12 $ 2 Held through mutual and pooled funds measured at net asset value 34 — — Fixed Income Held directly U.S. government and municipals 157 141 16 U.S. corporate debt 21 — 21 Held through mutual and pooled funds measured at net asset value U.S. government and municipals 149 — — U.S. corporate debt 623 — — International bonds 1,236 — — Equity Held directly U.S. equity 58 58 — International equity 30 30 — Held through mutual and pooled funds measured at net asset value Non-U.S. equity 67 — — Global equity 630 — — Total Plan Assets $ 3,019 $ 241 $ 39
Estimated Future Benefit Payments	Pension Benefits Other Benefits 2017 $ 225 $ 59 2018 242 59 2019 239 60 2020 247 61 2021 248 62 2022-2026 1,236 303

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2016
Equity [Abstract]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net	The effect of the change in ownership interest is as follows: 2015 Net Income Attributable to Kimberly-Clark Corporation $ 1,013 Decrease in Kimberly-Clark Corporation's additional paid-in capital for acquisition (94 ) Change from net income attributable to Kimberly-Clark Corporation and transfers to noncontrolling interests $ 919
Components of AOCI attributable to Kimberly-Clark	The changes in the components of accumulated other comprehensive income ("AOCI") attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2014 $ (1,335 ) $ (1,924 ) $ (37 ) $ (16 ) Other comprehensive income (loss) before reclassifications (942 ) 39 35 53 (Income) loss reclassified from AOCI 37 (a) 872 (b) (1 ) (b) (48 ) Net current period other comprehensive income (loss) (905 ) 911 34 5 Shares purchased from noncontrolling interests and other (12 ) — — 1 Balance as of December 31, 2015 (2,252 ) (1,013 ) (3 ) (10 ) Other comprehensive income (loss) before reclassifications (99 ) (115 ) (27 ) 33 (Income) loss reclassified from AOCI — 31 (b) (1 ) (b) (18 ) Net current period other comprehensive income (loss) (99 ) (84 ) (28 ) 15 Balance as of December 31, 2016 $ (2,351 ) $ (1,097 ) $ (31 ) $ 5
Change in Components of Accumulated Other Comprehensive Income (Loss)	The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows: Year Ended December 31 2016 2015 2014 Unrealized translation $ (88 ) $ (882 ) $ (826 ) Tax effect (11 ) (23 ) 7 (99 ) (905 ) (819 ) Defined benefit pension plans Unrecognized net actuarial loss and transition amount Funded status recognition (230 ) (4 ) (624 ) Amortization included in net periodic benefit cost 52 75 100 2015 U.S. plan settlements (recorded in Other (income) and expense, net) — 1,355 — Currency and other 81 42 69 (97 ) 1,468 (455 ) Unrecognized prior service cost/credit Funded status recognition (1 ) 4 42 Amortization included in net periodic benefit cost (8 ) (12 ) (7 ) Currency and other (6 ) (2 ) (3 ) (15 ) (10 ) 32 Tax effect 28 (547 ) 167 (84 ) 911 (256 ) Other postretirement benefit plans Unrecognized net actuarial loss and transition amount and other (45 ) 55 (36 ) Tax effect 17 (21 ) 14 (28 ) 34 (22 ) Cash flow hedges and other Recognition of effective portion of hedges 44 66 18 Amortization included in net income (20 ) (53 ) (5 ) Currency and other (4 ) (7 ) 2 Tax effect (5 ) (1 ) 3 15 5 18 Other — (11 ) 9 Change in AOCI $ (196 ) $ 34 $ (1,070 )

Leases and Commitments (Tables)

Leases and Commitments (Tables)	12 Months Ended
	Dec. 31, 2016
Leases and Commitments
Future Minimum Obligations under Operating Leases	The future minimum obligations under operating leases having a noncancelable term in excess of one year are as follows: Year Ending December 31 2017 $ 187 2018 137 2019 94 2020 67 2021 39 Thereafter 73 Future minimum obligations $ 597

Objectives and Strategies for35

Objectives and Strategies for Using Derivatives (Tables)	12 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of fair values of derivative instruments	Set forth below is a summary of the fair values of our derivative instruments: Assets Liabilities 2016 2015 2016 2015 Foreign currency exchange contracts $ 38 $ 56 $ 44 $ 27 Commodity price contracts 5 — 2 15 Total $ 43 $ 56 $ 46 $ 42

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Analysis of the Provision for Income Taxes	An analysis of the provision for income taxes follows: Year Ended December 31 2016 2015 2014 Current income taxes United States $ 523 $ 223 $ 350 State 53 56 48 Other countries 361 394 387 Total 937 673 785 Deferred income taxes United States (40 ) (180 ) 67 State 31 (74 ) (16 ) Other countries (6 ) (1 ) 20 Total (15 ) (255 ) 71 Total provision for income taxes $ 922 $ 418 $ 856
Income before Income Taxes	Income from continuing operations before income taxes is earned in the following tax jurisdictions: Year Ended December 31 2016 2015 2014 United States $ 2,088 $ 451 $ 1,571 Other countries 921 884 684 Total income before income taxes $ 3,009 $ 1,335 $ 2,255
Deferred Income Tax assets (Liabilities)	Deferred income tax assets and liabilities are composed of the following: December 31 2016 2015 Deferred tax assets Pension and other postretirement benefits $ 499 $ 682 Tax credits and loss carryforwards 450 443 Share based compensation 86 82 Other 512 517 1,547 1,724 Valuation allowances (225 ) (274 ) Total deferred tax assets 1,322 1,450 Deferred tax liabilities Pension and other postretirement benefits 15 254 Property, plant and equipment, net 1,079 1,118 Investments in subsidiaries 190 186 Goodwill 83 64 Other 253 217 Total deferred tax liabilities 1,620 1,839 Net deferred tax assets (liabilities) $ (298 ) $ (389 )
Reconciliation of Income Tax Provision	Presented below is a reconciliation of the income tax provision computed at the U.S. federal statutory tax rate to the actual effective tax rate: Year Ended December 31 2016 2015 2014 U.S. statutory rate applied to income before income taxes 35.0 % 35.0 % 35.0 % Rate of state income taxes, net of federal tax benefit 1.8 (0.9 ) 0.7 Statutory rates other than U.S. statutory rate (2.7 ) (6.9 ) (3.0 ) Venezuela deconsolidation, balance sheet remeasurement and inflationary impacts (0.1 ) 4.5 4.9 Uncertain tax positions adjustment (a) — 3.7 — Routine tax incentives (4.0 ) (7.4 ) (3.6 ) Net tax cost on foreign income 0.1 5.1 3.6 Other - net (b) 0.5 (1.8 ) 0.4 Effective income tax rate 30.6 % 31.3 % 38.0 %
Unrecognized Income Tax Benefits	Presented below is a reconciliation of the beginning and ending amounts of unrecognized income tax benefits: 2016 2015 2014 Balance at January 1 $ 406 $ 416 $ 473 Gross increases for tax positions of prior years 20 80 36 Gross decreases for tax positions of prior years (104 ) (61 ) (91 ) Gross increases for tax positions of the current year 39 59 87 Settlements (29 ) (63 ) (77 ) Other (11 ) (25 ) (12 ) Balance at December 31 $ 321 $ 406 $ 416
Summary of Income Tax Examinations	As of December 31, 2016 , the following tax years remain subject to examination for the major jurisdictions where we conduct business: Jurisdiction Years United States 2014 to 2016 United Kingdom 2012 to 2016 Brazil 2011 to 2016 Korea 2014 to 2016 China 2007 to 2016

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Average Common Shares Outstanding Basic and Diluted	The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows: (Millions of shares) 2016 2015 2014 Basic 359.4 363.8 374.5 Dilutive effect of stock options and restricted share unit awards 2.3 2.5 2.9 Diluted 361.7 366.3 377.4
Options Outstanding not Included in Computation of Diluted EPS	Options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares were insignificant.

Business Segment and Geographic

Business Segment and Geographic Data Information (Tables)	12 Months Ended
	Dec. 31, 2016
Segment Reporting Information
Information Concerning Consolidated Operations by Business Segment	Information concerning consolidated operations by business segment is presented in the following tables: Consolidated Operations by Business Segment Year Ended December 31 2016 2015 2014 NET SALES (a) Personal Care $ 9,046 $ 9,204 $ 9,635 Consumer Tissue 5,967 6,121 6,645 K-C Professional 3,150 3,219 3,388 Corporate & Other 39 47 56 TOTAL NET SALES $ 18,202 $ 18,591 $ 19,724 OPERATING PROFIT (b) Personal Care $ 1,857 $ 1,885 $ 1,803 Consumer Tissue 1,117 1,073 1,062 K-C Professional 603 590 604 Corporate & Other (c) (252 ) (367 ) (495 ) Other (income) and expense, net (d) 8 1,568 453 TOTAL OPERATING PROFIT $ 3,317 $ 1,613 $ 2,521 (a) Net sales in the United States to third parties totaled $8,874 , $8,819 and $8,573 in 2016 , 2015 and 2014 , respectively. (b) Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments. (c) Corporate & Other includes charges related to the 2014 Organization Restructuring of $38 , $63 and $133 in 2016, 2015 and 2014, respectively, and $5 and $41 related to the remeasurement of the Venezuelan balance sheet in 2015 and 2014 , respectively. Corporate & Other also includes charges of $23 for restructuring in Turkey in 2015 , and $33 related to European strategic changes in 2014 . (d) Other (income) and expense, net for 2016 and 2015 includes income of $11 and a charge of $108 , respectively, related to the deconsolidation of our Venezuelan operations, and for 2015 and 2014 includes charges of $40 and $421 , respectively, related to the remeasurement of the Venezuelan balance sheet. In addition, 2015 includes $1,358 for charges related to pension settlements, and 2014 includes a charge of $35 related to a regulatory dispute in the Middle East. Personal Care Consumer Tissue K-C Professional Corporate & Other Ongoing Operations Health Care Business (Spun-off) Consolidated Total Depreciation and Amortization 2016 $ 305 $ 280 $ 116 $ 4 $ 705 $ — $ 705 2015 340 282 121 3 746 — 746 2014 359 299 132 3 793 69 862 Assets 2016 6,141 4,761 2,151 1,549 14,602 — 14,602 2015 6,330 5,050 2,264 1,198 14,842 — 14,842 2014 6,373 5,229 2,339 1,585 15,526 — 15,526 Capital Spending 2016 421 250 95 5 771 — 771 2015 590 344 116 6 1,056 — 1,056 2014 501 314 143 6 964 75 1,039
Sales of Principal Products	(Billions of dollars) 2016 2015 2014 Consumer tissue products $ 6.0 $ 6.1 $ 6.6 Baby and child care products 6.4 6.6 7.0 Away-from-home professional products 3.1 3.2 3.4 All other 2.7 2.7 2.7 Consolidated $ 18.2 $ 18.6 $ 19.7

Supplemental Data (Tables)

Supplemental Data (Tables)	12 Months Ended
	Dec. 31, 2016
Supplemental Income Statement Data	Supplemental Income Statement Data Year Ended December 31 2016 2015 2014 Advertising expense $ 665 $ 710 $ 767 Research expense 328 324 368
Equity Method Investments Data	Equity Companies' Data Net Sales Gross Profit Operating Profit Net Income Corporation's Share of Net Income 2016 $ 2,138 $ 720 $ 454 $ 276 $ 132 2015 2,255 773 497 308 149 2014 2,452 781 485 304 146 Current Assets Non- Current Assets Current Liabilities Non- Current Liabilities Stockholders' Equity 2016 $ 963 $ 1,168 $ 531 $ 1,046 $ 554 2015 1,103 993 508 1,068 520 2014 1,016 1,040 690 963 403
Supplemental Balance Sheet Data	December 31 Summary of Property, Plant and Equipment, Net 2016 2015 Land $ 163 $ 164 Buildings 2,612 2,537 Machinery and equipment 13,591 13,393 Construction in progress 488 453 16,854 16,547 Less accumulated depreciation (9,685 ) (9,443 ) Total $ 7,169 $ 7,104 Property, plant and equipment, net in the United States as of December 31, 2016 and 2015 was $3,638 and $3,716 , respectively.
Schedule of Accrued Liabilities	December 31 Summary of Accrued Expenses 2016 2015 Accrued advertising and promotion $ 373 $ 339 Accrued salaries and wages 426 392 Accrued rebates 220 229 Accrued taxes - income and other 259 329 Accrued interest 96 82 Derivatives 44 36 Other 357 343 Total $ 1,775 $ 1,750
Supplemental Cash Flow Data	Supplemental Cash Flow Statement Data Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital Year Ended December 31 2016 2015 2014 Accounts receivable $ (23 ) $ 60 $ 267 Inventories 230 (28 ) 12 Trade accounts payable (61 ) 44 (30 ) Accrued expenses 26 (110 ) (120 ) Accrued income taxes 121 (81 ) (159 ) Derivatives 43 (63 ) 103 Currency and other (2 ) (267 ) (249 ) Total $ 334 $ (445 ) $ (176 )
Accounts Receivable, Net
Supplemental Balance Sheet Data	December 31 Summary of Accounts Receivable, Net 2016 2015 From customers $ 2,077 $ 2,017 Other 167 329 Less allowance for doubtful accounts and sales discounts (68 ) (65 ) Total $ 2,176 $ 2,281
Inventories
Supplemental Balance Sheet Data	December 31 2016 2015 Summary of Inventories by Major Class LIFO Non- LIFO Total LIFO Non- LIFO Total Raw materials $ 93 $ 236 $ 329 $ 100 $ 297 $ 397 Work in process 114 89 203 110 93 203 Finished goods 430 600 1,030 525 689 1,214 Supplies and other — 280 280 — 278 278 637 1,205 1,842 735 1,357 2,092 Excess of FIFO or weighted-average cost over LIFO cost (163 ) — (163 ) (183 ) — (183 ) Total $ 474 $ 1,205 $ 1,679 $ 552 $ 1,357 $ 1,909
Other Cash Flow Data and Interest Expense
Supplemental Cash Flow Data	Year Ended December 31 Other Cash Flow Data 2016 2015 2014 Interest paid $ 315 $ 308 $ 300 Income taxes paid 744 695 926

Valuation and Qualifying Acco40

Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2016
Valuation and Qualifying Accounts [Abstract]
Schedule of Valuation and Qualifying Accounts [Table Text Block]	KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS FOR THE YEARS ENDED DECEMBER 31, 2016 , 2015 AND 2014 (Millions of dollars) Description Balance at Beginning of Period Additions Deductions Charged to Costs and Expenses Charged to Other Accounts (a) Write-Offs and Reclassifications Balance at End of Period December 31, 2016 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 50 $ 8 $ 3 $ 11 (b) $ 50 Allowances for sales discounts 15 254 — 251 (c) 18 December 31, 2015 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 50 $ 12 $ (10 ) $ 2 (b) $ 50 Allowances for sales discounts 16 256 (1 ) 256 (c) 15 December 31, 2014 Allowances deducted from assets to which they apply Allowance for doubtful accounts $ 51 $ 13 $ (7 ) $ 7 (b) $ 50 Allowances for sales discounts 20 265 (1 ) 268 (c) 16 (a) Includes bad debt recoveries and the effects of changes in foreign currency exchange rates. (b) Primarily uncollectible receivables written off. (c) Sales discounts allowed. Additions Description Balance at Beginning of Period Charged to Costs and Expenses Charged to Other Accounts Deductions (a) Balance at End of Period December 31, 2016 Deferred taxes Valuation allowance $ 274 $ (45 ) $ — $ 4 $ 225 December 31, 2015 Deferred taxes Valuation allowance $ 215 $ 78 $ — $ 19 $ 274 December 31, 2014 Deferred taxes Valuation allowance $ 197 $ 30 $ — $ 12 $ 215 (a) Represents the net currency effects of translating valuation allowances at current rates of exchange.

Accounting Policies (Narrative)

Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Adjustments related to Venezuelan operations	$ (11)	$ 153	$ 462
K-C Venezuela
Adjustments related to Venezuelan operations		45	$ 462
K-C Venezuela | After Tax
Deconsolidation, Gain (Loss), Amount		(102)
K-C Venezuela | Before Tax
Deconsolidation, Gain (Loss), Amount	$ 11	$ (108)
Trademarks | Minimum
Intangible assets estimated useful life	2 years
Trademarks | Maximum
Intangible assets estimated useful life	20 years
Patents and developed technologies | Minimum
Intangible assets estimated useful life	5 years
Patents and developed technologies | Maximum
Intangible assets estimated useful life	15 years
Other | Minimum
Intangible assets estimated useful life	5 years
Other | Maximum
Intangible assets estimated useful life	15 years
Building
Estimated useful life	40 years
Machinery and Equipment | Minimum
Estimated useful life	16 years
Machinery and Equipment | Maximum
Estimated useful life	20 years
Software
Estimated useful life	5 years

2014 Organization Restructuri42

2014 Organization Restructuring Narrative (Details) - USD ($) $ in Millions	12 Months Ended			27 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016
2014 Organization Restructuring
Restructuring Cost and Reserve
Cash payments related to restructuring	$ 60	$ 86
After Tax
Restructuring Cost and Reserve
Restructuring Charges		$ 42	$ 95
After Tax | 2014 Organization Restructuring
Restructuring Cost and Reserve
Restructuring Charges	$ 27			$ 164
Before Tax | 2014 Organization Restructuring
Restructuring Cost and Reserve
Restructuring Charges				$ 231

2014 Organization Restructuri43

2014 Organization Restructuring Tables (Details) - USD ($) $ in Millions	12 Months Ended			27 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016
Restructuring Cost and Reserve
Income Tax Expense (Benefit)	$ 922	$ 418	$ 856
2014 Organization Restructuring
Restructuring Cost and Reserve
Income Tax Expense (Benefit)	(8)	(21)	(38)
2014 Organization Restructuring | Cost of products sold
Restructuring Cost and Reserve
Restructuring Charges	6	23	40
2014 Organization Restructuring | Marketing, research and general Expenses
Restructuring Cost and Reserve
Restructuring Charges	32	40	93
2014 Organization Restructuring | Other Operating Income (Expense)
Restructuring Cost and Reserve
Restructuring Charges	(3)	0	0
After Tax
Restructuring Cost and Reserve
Restructuring Charges		$ 42	$ 95
After Tax | 2014 Organization Restructuring
Restructuring Cost and Reserve
Restructuring Charges	$ 27			$ 164
Before Tax | 2014 Organization Restructuring
Restructuring Cost and Reserve
Restructuring Charges				$ 231

Spinoff of Health Care Busine44

Spinoff of Health Care Business and Related Costs - Narrative (Details) - Health Care Spin-off $ in Millions	10 Months Ended
	Oct. 31, 2014USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations
Transaction and related costs, pre-tax	$ 157
Transaction and related costs, after tax	$ 138

European Strategic Changes (Nar

European Strategic Changes (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2014USD ($)
European Strategic Changes
Restructuring Cost and Reserve
Net charges	$ 30

Fair Value Information Narrativ

Fair Value Information Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Inputs, Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Company-owned life insurance (COLI)	$ 61	$ 57
Derivative assets	43	56
Derivative liabilities	46	42
Fair Value, Inputs, Level 3 | Preferred securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure	$ (58)	$ (64)

Fair Value Information (Fair Va

Fair Value Information (Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions		Dec. 31, 2016	Dec. 31, 2015
Fair Value, Inputs, Level 1 | Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Cash and cash equivalents(a)	[1]	$ 923	$ 619
Time Deposits and Other Fair Value Disclosure	[2]	138	124
Fair Value, Inputs, Level 1 | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Cash and cash equivalents(a)	[1]	923	619
Time Deposits and Other Fair Value Disclosure	[2]	138	124
Fair Value, Inputs, Level 2 | Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Short-term debt(c)	[3]	170	1,071
Long-term debt(d)	[4]	7,402	6,704
Fair Value, Inputs, Level 2 | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Short-term debt(c)	[3]	170	1,071
Long-term debt(d)	[4]	$ 7,886	$ 7,300
[1]	Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
[2]	Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the consolidated balance sheet, as appropriate. Other, included in other current assets, is composed of funds held in escrow. Time deposits and other are recorded at cost, which approximates fair value.
[3]	Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
[4]	Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Acquisitions and Intangible Ass

Acquisitions and Intangible Assets (Changes in the Carrying Amount of Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Goodwill
Goodwill, Beginning Balance	$ 1,446	$ 1,628
Currency	34	(182)
Goodwill, Ending Balance	1,480	1,446
Personal Care
Goodwill
Goodwill, Beginning Balance	533	625
Currency	16	(92)
Goodwill, Ending Balance	549	533
Consumer Tissue
Goodwill
Goodwill, Beginning Balance	524	594
Currency	14	(70)
Goodwill, Ending Balance	538	524
K-C Professional and Other
Goodwill
Goodwill, Beginning Balance	389	409
Currency	4	(20)
Goodwill, Ending Balance	$ 393	$ 389

Acquisitions and Intangible A49

Acquisitions and Intangible Assets (Other Intangible Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Indefinite-lived Intangible Assets
Gross Carrying Amount	$ 213	$ 216
Accumulated Amortization	130	122
Trademarks
Indefinite-lived Intangible Assets
Gross Carrying Amount	108	109
Accumulated Amortization	79	77
Patents and developed technologies
Indefinite-lived Intangible Assets
Gross Carrying Amount	47	47
Accumulated Amortization	14	11
Other
Indefinite-lived Intangible Assets
Gross Carrying Amount	58	60
Accumulated Amortization	$ 37	$ 34

Debt and Redeemable Preferred50

Debt and Redeemable Preferred Securities of Subsidiaries (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Mar. 31, 2016	Sep. 30, 2015	Mar. 31, 2015	Jun. 30, 2014
Debt Instrument
Scheduled maturity of long-term debt in 2017	$ 965
Scheduled maturity of long-term debt in 2018	936
Scheduled maturity of long-term debt in 2019	711
Scheduled maturity of long-term debt in 2020	757
Scheduled maturity of long-term debt in 2021	249
Redeemable Preferred Securities of Subsidiaries	58	$ 64	$ 500
Expiring 2,021
Debt Instrument
Revolving credit facility	$ 2,000
Expiration date of revolving credit facility	Jun. 30, 2021
Dealer Remarketable Securities
Debt Instrument
Debt Instrument, Repurchase Amount		$ 200
3.20% Notes due July 30, 2046
Debt Instrument
Debt issuance date	Jul. 29, 2016
Face amount of note				$ 500
Debt maturity date	Jul. 30, 2046
Interest rate of note				3.20%
1.40% Notes due February 15, 2019
Debt Instrument
Debt issuance date	Feb. 22, 2016
Face amount of note					$ 400
Debt maturity date	Feb. 15, 2019
Interest rate of note						1.40%
2.75% Notes due February 15, 2026
Debt Instrument
Face amount of note					$ 400
Debt maturity date	Feb. 15, 2026
Interest rate of note					2.75%
2.15% Notes due August 15, 2020
Debt Instrument
Debt issuance date		Aug. 1, 2015
Face amount of note						$ 250
Debt maturity date		Aug. 15, 2020
Interest rate of note						2.15%
3.05% Notes due August 15, 2025
Debt Instrument
Face amount of note						$ 300
Debt maturity date		Aug. 15, 2025
Interest rate of note						3.05%
Notes due August 2015
Debt Instrument
Face amount of note						$ 300
1.85% Notes due March 1, 2020
Debt Instrument
Debt issuance date		Feb. 1, 2015
Face amount of note							$ 250
Debt maturity date		Mar. 1, 2020
Interest rate of note							1.85%
2.65% Notes due March 1, 2025
Debt Instrument
Face amount of note							$ 250
Debt maturity date		Mar. 1, 2025
Interest rate of note							2.65%
Aggregate principle amount due October 15, 2022
Debt Instrument
Debt issuance date			Oct. 17, 2014
Health Care Spin-off
Debt Instrument
Face amount of note			$ 640
Floating rate note due May 19, 2016
Debt Instrument
Debt issuance date			May 22, 2014
Face amount of note								$ 300
Debt maturity date			May 19, 2016
1.9% Notes due May 22, 2019
Debt Instrument
Face amount of note								$ 300
Debt maturity date			May 22, 2019
Interest rate of note								1.90%

Debt and Redeemable Preferred51

Debt and Redeemable Preferred Securities of Subsidiaries (Long-Term Debt) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument
Total long-term debt	$ 7,402	$ 6,704
Less current portion	963	598
Long-term portion	$ 6,439	6,106
Notes and Debentures
Debt Instrument
Weighted- Average Interest Rate	4.30%
Maturities (start)	Jan. 1, 2016
Maturities (end)	Dec. 31, 2045
Total long-term debt	$ 7,101	6,396
Industrial Development Revenue Bonds
Debt Instrument
Weighted- Average Interest Rate	0.20%
Maturities (start)	Jan. 1, 2018
Maturities (end)	Dec. 31, 2034
Total long-term debt	$ 264	264
Bank Loans And Other Financings In Various Currencies
Debt Instrument
Weighted- Average Interest Rate	5.40%
Maturities (start)	Jan. 1, 2016
Maturities (end)	Dec. 31, 2025
Total long-term debt	$ 37	$ 44

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award
Shares of common stock available for grants	18,000,000
Stock-based compensation	$ 77	$ 75	$ 52
Deferred income tax benefits on stock-based compensation	$ 28	$ 29	$ 19
Weighted-average fair value of options granted	$ 10.95	$ 7.39	$ 7.89
Excess tax benefits	$ 19	$ 37	$ 37
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Stock options term, years	10 years
Vesting percentage at the end of each of the first two 12 months period	30.00%
Vesting percentage at the end of third 12 months period	40.00%
Total intrinsic value of options exercised	$ 55	83	79
Restricted share units
Share-based Compensation Arrangement by Share-based Payment Award
Restricted shares vesting period	3 years
Performance-based restricted share units | Minimum | Share-based Compensation Award, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award
Number of performance-based share units that vest, percentage	0.00%
Performance-based restricted share units | Maximum | Share-based Compensation Award, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award
Number of performance-based share units that vest, percentage	200.00%
Restricted Share Units
Share-based Compensation Arrangement by Share-based Payment Award
Total fair value of restricted shares and restricted share units	$ 83	$ 99	$ 102

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of Assumptions Used to Estimate Weighted-Average Fair Value of Options Granted) (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Dividend yield	3.10%	3.50%	3.50%
Volatility	16.00%	13.40%	13.40%
Risk-free interest rate	1.20%	1.50%	1.70%
Expected life - years	4 years 7 months 6 days	4 years 9 months 18 days	5 years

Stock-Based Compensation (Sch54

Stock-Based Compensation (Schedule of Unrecognized Compensation Costs and Amortization Periods) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Nonvested stock options	$ 10
Weighted-Average Service Years	1 year 4 months 24 days
Restricted share units
Share-based Compensation Arrangement by Share-based Payment Award
Total remaining unrecognized compensation costs, nonvested awards other than options	$ 6
Weighted-Average Service Years	1 year 6 months
Performance-based restricted share units
Share-based Compensation Arrangement by Share-based Payment Award
Total remaining unrecognized compensation costs, nonvested awards other than options	$ 53
Weighted-Average Service Years	1 year 9 months 18 days

Stock-Based Compensation (Sch55

Stock-Based Compensation (Schedule of Stock-Based Compensation Activity) (Details) - Employee Stock Option $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding
Outstanding at January 1, 2016 | shares	6,590
Granted | shares	1,627
Exercised | shares	(1,249)
Forfeited or expired | shares	(175)
Outstanding at December 31, 2016 | shares	6,793
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding at January 1, Weighted-Average Exercise Price | $ / shares	$ 92.35
Granted, Weighted-Average Exercise Price | $ / shares	126.17
Exercised, Weighted-Average Exercise Price | $ / shares	85.75
Forfeited or expired, Weighted-Average Exercise Price | $ / shares	112.24
Outstanding at December 31, Weighted-Average Exercise Price | $ / shares	$ 101.16
Exercisable at December 31, 2016 | shares	3,667
Exercisable at December 31, Weighted-Average Exercise Price | $ / shares	$ 86.87
Outstanding at December 31, Weighted-Average Remaining Contractual Term	6 years 7 months 13 days
Exercisable at December 31, Weighted-Average Remaining Contractual Term	4 years 10 months 10 days
Outstanding at December 31, Aggregate Intrinsic Value | $	$ 107
Exercisable at December 31, Aggregate Intrinsic Value | $	$ 100

Stock-Based Compensation (Sch56

Stock-Based Compensation (Schedule of Other Stock-Based Awards Activity) (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2016$ / sharesshares
Time-Vested Restricted Share Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Nonvested at January 1, 2016 | shares	102
Granted | shares	75
Vested | shares	(61)
Forfeited | shares	(5)
Nonvested at December 31, 2016 | shares	111
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Nonvested at January 1, 2016, Weighted-Average Grant-Date Fair Value | $ / shares	$ 108.91
Granted, Weighted-Average Grant-Date Fair Value | $ / shares	120.96
Vested, Weighted-Average Grant-Date Fair Value | $ / shares	107.17
Forfeited, Weighted-Average Grant-Date Fair Value | $ / shares	116.53
Nonvested at December 31, 2016, Weighted-Average Grant-Date Fair Value | $ / shares	$ 117.63
Performance-Based Restricted Share Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Nonvested at January 1, 2016 | shares	1,761
Granted | shares	625
Vested | shares	(646)
Forfeited | shares	(98)
Nonvested at December 31, 2016 | shares	1,642
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Nonvested at January 1, 2016, Weighted-Average Grant-Date Fair Value | $ / shares	$ 107.51
Granted, Weighted-Average Grant-Date Fair Value | $ / shares	126.05
Vested, Weighted-Average Grant-Date Fair Value | $ / shares	101.17
Forfeited, Weighted-Average Grant-Date Fair Value | $ / shares	113.41
Nonvested at December 31, 2016, Weighted-Average Grant-Date Fair Value | $ / shares	$ 116.53

Employee Postretirement Benef57

Employee Postretirement Benefits (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2028	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan, Significant Concentrations of Risk				there were no significant concentrations of equity or debt securities in any single issuer or industry.
Defined Contribution Plan, Cost Recognized				$ 126	$ 107	$ 121
Scenario, Forecast
Defined Benefit Plan, Health Care Cost Trend Rate Assumed For Ultimate Fiscal Year		4.60%
Defined Benefit Plan, Year that Rate Reaches Ultimate Trend Rate		2,028
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year			6.00%
Group Annuity Contracts that Transferred | UNITED STATES
Defined Benefit Plan, Benefit Obligation	$ 2,500
Defined Benefit Pension Plans
Defined Benefit Plan, Benefit Obligation				4,126	3,959	6,860
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements				(1)	(1,357)	$ (20)
Cash contribution to pension trusts				$ 108	$ 484
Weighted-average expected long-term rate or return				4.84%	5.21%	5.98%
Defined Benefit Pension Plans | Scenario, Forecast
Weighted-average expected long-term rate or return			4.46%
Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year			$ 100
Defined Benefit Pension Plans | UNITED STATES
Cash contribution to pension trusts					$ 410
Principal Plans
Defined Benefit Plan, Benefit Obligation				$ 3,427	$ 3,295
Weighted-average expected long-term rate or return				5.10%	5.35%
Principal Plans | Scenario, Forecast
Weighted-average expected long-term rate or return			4.72%
Fixed Income Funds | Scenario, Forecast
Defined Benefit Plan, Target Plan Asset Allocations			70.00%
Equity Securities | Scenario, Forecast
Defined Benefit Plan, Target Plan Asset Allocations			30.00%
Treasury Futures | U.S. Pension Plan
Derivative, Notional Amount				$ 216	$ 15
After Tax | Defined Benefit Pension Plans | UNITED STATES
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements	(800)
Before Tax | Defined Benefit Pension Plans | UNITED STATES
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Settlements	$ (1,400)

Employee Postretirement Benef58

Employee Postretirement Benefits (Summarized Financial Information about Postretirement plans, Excluding Defined Contribution Retirement Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Pension Plans
Benefit obligation at beginning of year	$ 3,959	$ 6,860
Service cost	42	38	$ 46
Interest cost	148	187	279
Actuarial loss (gain)	501	(150)
Currency and other	(304)	(139)
Benefit payments from plans	(202)	(235)
Direct benefit payments	(15)	(12)
Settlements	(3)	(2,590)
Benefit obligation at end of year	4,126	3,959	6,860
Fair value of plan assets at beginning of year	3,508	5,914
Actual return on plan assets	413	54
Employer contributions	108	484
Currency and other	(290)	(119)
Benefit payments	(202)	(235)
Settlements	(3)	(2,590)
Fair value of plan assets at end of year	3,534	3,508	5,914
Funded Status	(592)	(451)
Other Postretirement Benefit Plans
Service cost	11	12	13
Interest cost	33	32	35
Settlements	0	0
Other Postretirement Benefit Plans, Defined Benefit
Benefit obligation at beginning of year	717	788
Service cost	11	12
Interest cost	33	32
Actuarial loss (gain)	41	(53)
Currency and other	9	(8)
Benefit payments from plans	0	0
Direct benefit payments	(53)	(54)
Benefit obligation at end of year	758	717	788
Fair value of plan assets at beginning of year	0	0
Actual return on plan assets	0	0
Employer contributions	0	0
Currency and other	0	0
Benefit payments	0	0
Settlements	0	0
Fair value of plan assets at end of year	0	0	$ 0
Funded Status	$ (758)	$ (717)

Employee Postretirement Benef59

Employee Postretirement Benefits (Principal Plans and All Other Pension Plans) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Principal Plans
Defined Benefit Plan, Benefit Obligation	$ 3,427	$ 3,295
Defined Benefit Plan, Accumulated Benefit Obligation	3,378	3,253
Fair value of plan assets	3,011	3,019
All Other Pension Plans
Defined Benefit Plan, Benefit Obligation	699	664
Defined Benefit Plan, Accumulated Benefit Obligation	622	594
Fair value of plan assets	523	489
Defined Benefit Pension Plans
Defined Benefit Plan, Benefit Obligation	4,126	3,959	$ 6,860
Defined Benefit Plan, Accumulated Benefit Obligation	4,000	3,847
Fair value of plan assets	$ 3,534	$ 3,508	$ 5,914

Employee Postretirement Benef60

Employee Postretirement Benefits (Pension Plans with an ABO in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
PBO	$ 3,807	$ 2,115
ABO	3,736	2,096
Fair value of plan assets	$ 3,243	$ 1,696

Employee Postretirement Benef61

Employee Postretirement Benefits (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Pension Plans
Service cost		$ 42	$ 38	$ 46
Interest cost		148	187	279
Expected return on plan assets(a)	[1]	(158)	(215)	(332)
Recognized net actuarial loss		52	75	100
Settlements		1	1,357	20
Other		(9)	(10)	(3)
Net periodic benefit cost		76	1,432	110
Other Postretirement Benefit Plans
Service cost		11	12	13
Interest cost		33	32	35
Expected return on plan assets(a)		0	0	0
Recognized net actuarial loss		0	0	0
Settlements		0	0	0
Other		(1)	(1)	(1)
Net periodic benefit cost		$ 43	$ 43	$ 47
[1]	The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.

Employee Postretirement Benef62

Employee Postretirement Benefits (Weighted-Average Assumptions) (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Pension Plans
Net cost, Discount rate		3.91%	3.86%	4.66%
Net cost, Expected long-term return on plan assets		4.84%	5.21%	5.98%
Net cost, Rate of compensation increase		2.32%	2.63%	2.67%
Benefit obligations, Discount rate		3.19%	3.91%
Benefit obligations, Rate of compensation increase		2.29%	2.32%
Defined Benefit Pension Plans | Scenario, Forecast
Net cost, Discount rate	3.19%
Net cost, Expected long-term return on plan assets	4.46%
Net cost, Rate of compensation increase	2.29%
Other Postretirement Benefit Plans
Net cost, Discount rate		4.59%	4.28%	4.97%
Net cost, Expected long-term return on plan assets		0.00%	0.00%	0.00%
Net cost, Rate of compensation increase		0.00%	0.00%	0.00%
Benefit obligations, Discount rate		4.29%	4.59%
Benefit obligations, Rate of compensation increase		0.00%	0.00%

Employee Postretirement Benef63

Employee Postretirement Benefits (Pension Plan Assets of the Principal Plans Measured at fair value) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Pension Plans
Fair value of plan assets	$ 3,534	$ 3,508	$ 5,914
Principal Plans
Fair value of plan assets	3,011	3,019
Principal Plans | Fair Value, Inputs, Level 1
Fair value of plan assets	240	241
Principal Plans | Fair Value, Inputs, Level 2
Fair value of plan assets	0	39
Principal Plans | Cash and Cash Equivalents
Fair value of plan assets	33	14
Principal Plans | Cash and Cash Equivalents | Mutual and Pooled Funds | Net Asset Value or Its Equivalent
Fair value of plan assets	17	34
Principal Plans | Cash and Cash Equivalents | Fair Value, Inputs, Level 1
Fair value of plan assets	33	12
Principal Plans | Cash and Cash Equivalents | Fair Value, Inputs, Level 1 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | Cash and Cash Equivalents | Fair Value, Inputs, Level 2
Fair value of plan assets	0	2
Principal Plans | Cash and Cash Equivalents | Fair Value, Inputs, Level 2 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | U.S. government and municipals
Fair value of plan assets	122	157
Principal Plans | U.S. government and municipals | Mutual and Pooled Funds | Net Asset Value or Its Equivalent
Fair value of plan assets	128	149
Principal Plans | U.S. government and municipals | Fair Value, Inputs, Level 1
Fair value of plan assets	122	141
Principal Plans | U.S. government and municipals | Fair Value, Inputs, Level 1 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | U.S. government and municipals | Fair Value, Inputs, Level 2
Fair value of plan assets	0	16
Principal Plans | U.S. government and municipals | Fair Value, Inputs, Level 2 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | U.S. corporate debt
Fair value of plan assets		21
Principal Plans | U.S. corporate debt | Mutual and Pooled Funds | Net Asset Value or Its Equivalent
Fair value of plan assets	648	623
Principal Plans | U.S. corporate debt | Fair Value, Inputs, Level 1
Fair value of plan assets		0
Principal Plans | U.S. corporate debt | Fair Value, Inputs, Level 1 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | U.S. corporate debt | Fair Value, Inputs, Level 2
Fair value of plan assets		21
Principal Plans | U.S. corporate debt | Fair Value, Inputs, Level 2 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | International Bonds | Mutual and Pooled Funds | Net Asset Value or Its Equivalent
Fair value of plan assets	1,223	1,236
Principal Plans | International Bonds | Fair Value, Inputs, Level 1 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | International Bonds | Fair Value, Inputs, Level 2 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | U.S. Equity
Fair value of plan assets	41	58
Principal Plans | U.S. Equity | Fair Value, Inputs, Level 1
Fair value of plan assets	41	58
Principal Plans | U.S. Equity | Fair Value, Inputs, Level 2
Fair value of plan assets	0	0
Principal Plans | International Equity
Fair value of plan assets	44	30
Principal Plans | International Equity | Fair Value, Inputs, Level 1
Fair value of plan assets	44	30
Principal Plans | International Equity | Fair Value, Inputs, Level 2
Fair value of plan assets	0	0
Principal Plans | Non-U.S. Equity | Mutual and Pooled Funds | Net Asset Value or Its Equivalent
Fair value of plan assets	68	67
Principal Plans | Non-U.S. Equity | Fair Value, Inputs, Level 1 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | Non-U.S. Equity | Fair Value, Inputs, Level 2 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | Global equity | Mutual and Pooled Funds | Net Asset Value or Its Equivalent
Fair value of plan assets	687	630
Principal Plans | Global equity | Fair Value, Inputs, Level 1 | Mutual and Pooled Funds
Fair value of plan assets	0	0
Principal Plans | Global equity | Fair Value, Inputs, Level 2 | Mutual and Pooled Funds
Fair value of plan assets	$ 0	$ 0

Employee Postretirement Benef64

Employee Postretirement Benefits (Cash Contributions to its Pension Trusts) (Details) $ in Millions	Dec. 31, 2016USD ($)
Defined Benefit Pension Plans
2,017	$ 225
2,018	242
2,019	239
2,020	247
2,021	248
2022-2026	1,236
Other Postretirement Benefit Plans
2,017	59
2,018	59
2,019	60
2,020	61
2,021	62
2022-2026	$ 303

Employee Postretirement Benef65

Employee Postretirement Benefits (Defined Contribution Pension Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Costs charged to expense for defined contribution pension plans	$ 126	$ 107	$ 121

Stockholders' Equity (Narrative

Stockholders' Equity (Narratives) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2017	Dec. 31, 2016
Noncontrolling Interest
Unrecognized net actuarial loss			$ 1,162
Unrecognized net prior service credit			$ 34
Scenario, Forecast
Noncontrolling Interest
Defined Benefit Plan, Amortization of Net Gains (Losses)		$ 57
Defined Benefit Plan, Amortization of Net Prior Service Cost (Credit)		$ 9
Israel
Noncontrolling Interest
Noncontrolling interest acquired	49.90%
Payment to noncontrolling interest acquired	$ 151
Kimberly-Clark Tuketim Mallari Sanayi ve Ticaret A.s.
Noncontrolling Interest
Noncontrolling interest acquired	49.90%

Stockholders' Equity Effect of

Stockholders' Equity Effect of Change in Ownership (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Stockholders' Equity [Abstract]
Net Income (Loss) Attributable to Parent	$ 2,166	$ 1,013	$ 1,526
Decrease in Kimberly-Clark Corporation's additional paid-in capital for acquisition		(94)
Change from net income attributable to Kimberly-Clark Corporation and transfers to noncontrolling interests		$ 919

Stockholders' Equity Components

Stockholders' Equity Components of AOCI attributable to Kimberly-Clark, net of tax (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015		Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		$ (3,278)
Net current period other comprehensive income (loss)		(205)	$ 25		$ (1,090)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(3,474)	(3,278)
Unrealized Translation
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(2,252)	(1,335)
Other comprehensive income (loss) before reclassifications		(99)	(942)
(Income) loss reclassified from AOCI		0	37	[1]
Net current period other comprehensive income (loss)		(99)	(905)
Shares purchased from noncontrolling interests and other			(12)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(2,351)	(2,252)		(1,335)
Defined Benefit Pension Plans and Other Postretirement Benefit Plans | Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(1,013)	(1,924)
Other comprehensive income (loss) before reclassifications		(115)	39
(Income) loss reclassified from AOCI	[2]	31	872
Net current period other comprehensive income (loss)		(84)	911
Shares purchased from noncontrolling interests and other			0
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(1,097)	(1,013)		(1,924)
Defined Benefit Pension Plans and Other Postretirement Benefit Plans | Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(3)	(37)
Other comprehensive income (loss) before reclassifications		(27)	35
(Income) loss reclassified from AOCI	[2]	(1)	(1)
Net current period other comprehensive income (loss)		(28)	34
Shares purchased from noncontrolling interests and other			0
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		(31)	(3)		(37)
Cash Flow Hedges and Other
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Beginning Balance		(10)	(16)
Other comprehensive income (loss) before reclassifications		33	53
(Income) loss reclassified from AOCI		(18)	(48)
Net current period other comprehensive income (loss)		15	5
Shares purchased from noncontrolling interests and other			1
Accumulated Other Comprehensive Income (Loss), Net of Tax, Ending Balance		$ 5	$ (10)		$ (16)
[1]	Included in other (income) and expense, net as part of the charge related to the deconsolidation of our Venezuelan operations at December 31, 2015 (see Note 1).
[2]	Included in computation of net periodic pension and postretirement benefits costs (see Note 9).

Stockholders' Equity Componen69

Stockholders' Equity Components of Stockholders' Equity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss)
Unrealized translation	$ (107)	$ (922)	$ (835)
Change in AOCI	(196)	34	(1,070)
Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
2015 U.S. plan settlements (recorded in Other (income) and expense, net)	1	1,357	20
Defined benefit pension plans, tax effect	28	(547)	167
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Net of Tax	(84)	911	(256)
Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
2015 U.S. plan settlements (recorded in Other (income) and expense, net)	0	0	0
Defined benefit pension plans, tax effect	17	(21)	14
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, Net of Tax	(28)	34	(22)
Other (Income) And Expense, Net
Accumulated Other Comprehensive Income (Loss)
Other	0	(11)	9
Attributable to Kimberly-Clark
Accumulated Other Comprehensive Income (Loss)
Unrealized translation, before tax	(88)	(882)	(826)
Unrealized translation, tax effect	(11)	(23)	7
Unrealized translation	(99)	(905)	(819)
Unrecognized net actuarial loss and transition amount | Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Funded status recognition	(230)	(4)	(624)
Amortization included in net periodic benefit cost	52	75	100
2015 U.S. plan settlements (recorded in Other (income) and expense, net)	0	(1,355)	0
Currency and other	81	42	69
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax	(97)	1,468	(455)
Unrecognized net actuarial loss and transition amount | Other Postretirement Benefit Plans
Accumulated Other Comprehensive Income (Loss)
Unrecognized net actuarial loss and transition amount ant other	(45)	55	(36)
Unrecognized prior service cost | Defined Benefit Pension Plans
Accumulated Other Comprehensive Income (Loss)
Funded status recognition	(1)	4	42
Currency and other	(6)	(2)	(3)
Amortization included in net periodic benefit cost	(8)	(12)	(7)
Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax	(15)	(10)	32
Cash Flow Hedges and Other
Accumulated Other Comprehensive Income (Loss)
Currency and other	(4)	(7)	2
Recognition of effective portion of hedges	44	66	18
Amortization included in net income	(20)	(53)	(5)
Cash flow hedges and other, tax effect	(5)	(1)	3
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	$ 15	$ 5	$ 18

Leases and Commitments (Narrati

Leases and Commitments (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Leases and Commitments
Consolidated rental expense	$ 271	$ 279	$ 303
2,017	681
2,018	184
2,019	187
2,020	$ 197

Leases and Commitments (Future

Leases and Commitments (Future Minimum Obligations under Operating Leases) (Details) $ in Millions	Dec. 31, 2016USD ($)
Leases and Commitments
2,017	$ 187
2,018	137
2,019	94
2,020	67
2,021	39
Thereafter	73
Future minimum obligations	$ 597

Objectives and Strategies for72

Objectives and Strategies for Using Derivatives (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended			36 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016
Fair value hedge ineffectiveness is immaterial assertion				Fair value hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2016
Gain from hedged firm commitment not qualifying as fair value hedge				$ 0
Cash flow hedge ineffectiveness is immaterial assertion				Cash flow hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2016
Gains or losses reclassified into earnings resulting from discontinuance of cash flow hedges				$ 0
Losses on undesignated foreign exchange hedging instruments recognized in other (income) and expense	$ 30	$ 188	$ 192
Cash Flow Hedging
Maximum maturity of cash flow hedges	Jan. 1, 2019
Not Designated as Hedging Instrument
Aggregate notional value	$ 1,900			1,900
Foreign Exchange Contract | Cash Flow Hedging
Aggregate notional value	$ 740			$ 740

Objectives and Strategies for73

Objectives and Strategies for Using Derivatives Objectives and Strategies for Using Derivatives (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Derivative
Assets	$ 43	$ 56
Liabilities	46	42
Foreign Exchange Contract
Derivative
Assets	38	56
Liabilities	44	27
Commodity Contract
Derivative
Assets	5	0
Liabilities	$ 2	$ 15

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2036	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2013	Dec. 31, 2010	Dec. 31, 2007	Dec. 31, 2005	Dec. 31, 2004	Dec. 31, 2015
Income Tax Examination [Line Items]
Operating Loss Carryforwards, Valuation Allowance			$ 700
Valuation Allowance
Income tax loss carryforwards, subject to expiration			473
Remaining amount of loss carryforwards that has no expiration date			251
Unremitted earnings			8,900
Unrecognized tax benefits			251
Total accrued penalties and net accrued interest			47						$ 40
Aggregate resolution of uncertainties			$ 140
Year federal income tax returns have been audited			2,013
Income Tax Examination, Year under Examination						2,007	2,005	2,004
Minimum [Member]
Valuation Allowance
Income Tax Examination, Year under Examination					2,010
Minimum [Member] | Scenario, Forecast
Valuation Allowance
Operating Loss Carryforwards, Expiration Date		Jan. 1, 2017
Maximum [Member]
Valuation Allowance
Income Tax Examination, Year under Examination				2,013
Maximum [Member] | Scenario, Forecast
Valuation Allowance
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2036

Income Taxes (Analysis of the P

Income Taxes (Analysis of the Provision for Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
United States	$ 523	$ 223	$ 350
State	53	56	48
Other countries	361	394	387
Total	937	673	785
United States	(40)	(180)	67
State	31	(74)	(16)
Other countries	(6)	(1)	20
Total	(15)	(255)	71
Total provision for income taxes	$ 922	$ 418	$ 856

Income Taxes (Income before Inc

Income Taxes (Income before Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
United States	$ 2,088	$ 451	$ 1,571
Other countries	921	884	684
Income From Continuing Operations Before Income Taxes and Equity Interests	$ 3,009	$ 1,335	$ 2,255

Income Taxes (Deferred Income T

Income Taxes (Deferred Income Tax Assets (Liabilities)) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Pension and other postretirement benefits	$ 499	$ 682
Tax credits and loss carryforwards	450	443
Share based compensation	86	82
Other	512	517
Deferred Tax Assets, Gross	1,547	1,724
Valuation allowances	(225)	(274)
Total deferred tax assets	1,322	1,450
Pension and other postretirement benefits	15	254
Property, plant and equipment, net	1,079	1,118
Investments in subsidiaries	190	186
Goodwill	83	64
Other	253	217
Total deferred tax liabilities	1,620	1,839
Net deferred tax assets (liabilities)	$ (298)	$ (389)

Income Taxes (Reconciliation of

Income Taxes (Reconciliation of Income Tax Provision) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Disclosure [Abstract]
U.S. statutory rate applied to income before income taxes		35.00%	35.00%	35.00%
Rate of state income taxes, net of federal tax benefit		1.80%	(0.90%)	0.70%
Statutory rates other than U.S. statutory rate		(2.70%)	(6.90%)	(3.00%)
Venezuela deconsolidation, balance sheet remeasurement and inflationary impacts		(0.10%)	4.50%	4.90%
Uncertain tax positions adjustment(a)	[1]	0.00%	3.70%	0.00%
Routine tax incentives		(4.00%)	(7.40%)	(3.60%)
Net tax cost on foreign income		0.10%	5.10%	3.60%
Other - net(b)	[2]	0.50%	(1.80%)	0.40%
Effective income tax rate		30.60%	31.30%	38.00%
Tax Adjustments, UTP			$ 49
[1]	In 2015, we updated our assessment of uncertain tax positions for certain international operations and as a result we recorded an immaterial income tax charge of $49 related to prior years.
[2]	Other - net is composed of numerous items, none of which is greater than 1.75 percent of income before income taxes.

Income Taxes (Unrecognized Inco

Income Taxes (Unrecognized Income Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns
Balance at January 1	$ 406	$ 416	$ 473
Gross increases for tax positions of prior years	20	80	36
Gross decreases for tax positions of prior years	(104)	(61)	(91)
Gross increases for tax positions of the current year	39	59	87
Settlements	(29)	(63)	(77)
Other	(11)	(25)	(12)
Balance at December 31	$ 321	$ 406	$ 416

Income Taxes (Remaining Tax Yea

Income Taxes (Remaining Tax Years Subject to Examination) (Details)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2013	Dec. 31, 2010	Dec. 31, 2007	Dec. 31, 2005	Dec. 31, 2004
Income Tax Examination
Income Tax Examination, Year under Examination				2,007	2,005	2,004
Minimum
Income Tax Examination
Income Tax Examination, Year under Examination			2,010
Minimum | United States
Income Tax Examination
Income Tax Examination, Year under Examination	2,014
Minimum | United Kingdom
Income Tax Examination
Income Tax Examination, Year under Examination	2,012
Minimum | Brazil
Income Tax Examination
Income Tax Examination, Year under Examination	2,011
Minimum | Korea
Income Tax Examination
Income Tax Examination, Year under Examination	2,014
Minimum | China
Income Tax Examination
Income Tax Examination, Year under Examination	2,007
Maximum
Income Tax Examination
Income Tax Examination, Year under Examination		2,013
Maximum | United States
Income Tax Examination
Income Tax Examination, Year under Examination	2,016
Maximum | United Kingdom
Income Tax Examination
Income Tax Examination, Year under Examination	2,016
Maximum | Brazil
Income Tax Examination
Income Tax Examination, Year under Examination	2,016
Maximum | Korea
Income Tax Examination
Income Tax Examination, Year under Examination	2,016
Maximum | China
Income Tax Examination
Income Tax Examination, Year under Examination	2,016

Earnings Per Share (Narratives)

Earnings Per Share (Narratives) (Details) - shares shares in Millions	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Earnings Per Share [Abstract]
Common shares outstanding	356.6	360.9	365.3

Earnings Per Share (Average Com

Earnings Per Share (Average Common shares Outstanding Basic and Diluted) (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Earnings Per Share [Abstract]
Basic	359.4	363.8	374.5
Dilutive effect of stock options and restricted share unit awards	2.3	2.5	2.9
Diluted	361.7	366.3	377.4

Business Segment and Geograph83

Business Segment and Geographic Data Information (Narrative) (Details) - USD ($) $ in Millions		12 Months Ended			27 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016
Charges related to Venezuelan Operations		$ 11	$ (153)	$ (462)
Other Operating Income (Expense), Net	[1],[2]	$ (8)	$ (1,568)	$ (453)
Net Sales Percentage to One Customer | Wal-Mart Stores, Inc.
Net sales to Wal-Mart Stores, percent		14.00%	14.00%	13.00%
K-C Venezuela
Charges related to Venezuelan Operations			$ (45)	$ (462)
Dispute in Middle East
Other Operating Income (Expense), Net				(35)
Corporate and Other | European Strategic Changes
Restructuring Charges				33
Other Income | K-C Venezuela
Charges related to Venezuelan Operations			(40)	(421)
Before Tax | 2014 Organization Restructuring | Corporate and Other
Restructuring Charges			63	$ 133
Before Tax | K-C Venezuela
Deconsolidation, Gain (Loss), Amount		$ 11	$ (108)
Before Tax | 2014 Organization Restructuring
Restructuring Charges					$ 231
Before Tax | 2014 Organization Restructuring | Corporate and Other
Restructuring Charges		$ 38
[1]	Other (income) and expense, net for 2016 and 2015 includes income of $11 and a charge of $108, respectively, related to the deconsolidation of our Venezuelan operations, and for 2015 and 2014 includes charges of $40 and $421, respectively, related to the remeasurement of the Venezuelan balance sheet. In addition, 2015 includes $1,358 for charges related to pension settlements, and 2014 includes a charge of $35 related to a regulatory dispute in the Middle East.
[2]	Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.

Business Segment and Geograph84

Business Segment and Geographic Data Information (Information Concerning Consolidated Operations by Business Segment) (Details) - USD ($) $ in Millions		12 Months Ended			27 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016
Net Sales		$ 18,202	$ 18,591	$ 19,724
Operating Profit		3,317	1,613	2,521
Depreciation and Amortization		705	746	862
Assets		14,602	14,842	15,526	$ 14,602
Capital Spending		771	1,056	1,039
Charge for Venezuelan Balance Sheet Remeasurement		(11)	153	462
Other Operating Income (Expense), Net	[1],[2]	8	1,568	453
United States
Net Sales		8,874	8,819	8,573
Personal Care
Net Sales	[3]	9,046	9,204	9,635
Operating Profit	[2]	1,857	1,885	1,803
Depreciation and Amortization		305	340	359
Assets		6,141	6,330	6,373	6,141
Capital Spending		421	590	501
Consumer Tissue
Net Sales	[3]	5,967	6,121	6,645
Operating Profit	[2]	1,117	1,073	1,062
Depreciation and Amortization		280	282	299
Assets		4,761	5,050	5,229	4,761
Capital Spending		250	344	314
K-C Professional and Other
Net Sales	[3]	3,150	3,219	3,388
Operating Profit	[2]	603	590	604
Depreciation and Amortization		116	121	132
Assets		2,151	2,264	2,339	2,151
Capital Spending		95	116	143
Corporate and Other
Net Sales	[3]	39	47	56
Operating Profit	[2],[4]	(252)	(367)	(495)
Depreciation and Amortization		4	3	3
Assets		1,549	1,198	1,585	1,549
Capital Spending		5	6	6
Ongoing Operations
Depreciation and Amortization		705	746	793
Assets		14,602	14,842	15,526	14,602
Capital Spending		771	1,056	964
Health Care
Depreciation and Amortization		0	0	69
Assets		0	0	0	0
Capital Spending		0	0	75
K-C Venezuela
Charge for Venezuelan Balance Sheet Remeasurement			45	462
K-C Turkey | Corporate and Other
Charges for workforce reductions and other exit costs			23
Dispute in Middle East
Other Operating Income (Expense), Net				35
Cost of Sales | K-C Venezuela
Charge for Venezuelan Balance Sheet Remeasurement			5	41
Cost of Sales | 2014 Organization Restructuring
Charges for workforce reductions and other exit costs		6	23	40
Other Income | K-C Venezuela
Charge for Venezuelan Balance Sheet Remeasurement			40	421
Corporate and Other
Defined Benefit Plan, Settlements, Plan Assets			1,358
Corporate and Other | European Strategic Changes
Charges for workforce reductions and other exit costs				33
Corporate and Other | Before Tax | 2014 Organization Restructuring
Charges for workforce reductions and other exit costs			63	$ 133
Before Tax | K-C Venezuela
Deconsolidation, Gain (Loss), Amount		(11)	$ 108
Before Tax | 2014 Organization Restructuring
Charges for workforce reductions and other exit costs					$ 231
Before Tax | Corporate and Other | 2014 Organization Restructuring
Charges for workforce reductions and other exit costs		$ 38
[1]	Other (income) and expense, net for 2016 and 2015 includes income of $11 and a charge of $108, respectively, related to the deconsolidation of our Venezuelan operations, and for 2015 and 2014 includes charges of $40 and $421, respectively, related to the remeasurement of the Venezuelan balance sheet. In addition, 2015 includes $1,358 for charges related to pension settlements, and 2014 includes a charge of $35 related to a regulatory dispute in the Middle East.
[2]	Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.
[3]	Net sales in the United States to third parties totaled $8,874, $8,819 and $8,573 in 2016, 2015 and 2014, respectively.
[4]	Corporate & Other includes charges related to the 2014 Organization Restructuring of $38, $63 and $133 in 2016, 2015 and 2014, respectively, and $5 and $41 related to the remeasurement of the Venezuelan balance sheet in 2015 and 2014, respectively. Corporate & Other also includes charges of $23 for restructuring in Turkey in 2015, and $33 related to European strategic changes in 2014.

Business Segment and Geograph85

Business Segment and Geographic Data Information (Sales of Principal Products) (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Sales of Principal Products	$ 18.2	$ 18.6	$ 19.7
Consumer Tissue Products
Sales of Principal Products	6	6.1	6.6
Baby and Child Care Products
Sales of Principal Products	6.4	6.6	7
Away from Home Professional Products
Sales of Principal Products	3.1	3.2	3.4
All Other
Sales of Principal Products	$ 2.7	$ 2.7	$ 2.7

Supplemental Data (Narrative) (

Supplemental Data (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Schedule of Equity Method Investments
Property, Plant and Equipment, Net	$ 7,169	$ 7,104
Investments in Equity Companies	257	247
Retained Earnings, Undistributed Earnings from Equity Method Investees	1,100
United States
Schedule of Equity Method Investments
Property, Plant and Equipment, Net	$ 3,638	$ 3,716
Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries
Schedule of Equity Method Investments
Equity Method Investment, Ownership Percentage	47.90%
Investments in Equity Companies	$ 188
Equity Method Investments, Fair Value Disclosure	$ 2,700

Supplemental Data (Supplemental

Supplemental Data (Supplemental Income Statement Data) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplemental Data
Advertising expense	$ 665	$ 710	$ 767
Research expense	$ 328	$ 324	$ 368

Supplemental Data Supplemental

Supplemental Data Supplemental Data (Equity Method Investment Data) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Net Sales	$ 2,138	$ 2,255	$ 2,452
Gross Profit	720	773	781
Operating Profit	454	497	485
Net Income	276	308	304
Corporation's Share of Net Income	132	149	146
Current Assets	963	1,103	1,016
Non- Current Assets	1,168	993	1,040
Current Liabilities	531	508	690
Non- Current Liabilities	1,046	1,068	963
Stockholders' Equity	$ 554	$ 520	$ 403

Supplemental Data (Summary of A

Supplemental Data (Summary of Accounts Receivable, Net) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Supplemental Data (Millions of dollars) [Abstract]
From customers	$ 2,077	$ 2,017
Other	167	329
Less allowance for doubtful accounts and sales discounts	(68)	(65)
Total	$ 2,176	$ 2,281

Supplemental Data (Summary of I

Supplemental Data (Summary of Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Inventory
Raw materials	$ 329	$ 397
Work in process	203	203
Finished goods	1,030	1,214
Supplies and other	280	278
Gross inventories	1,842	2,092
Excess of FIFO or weighted-average cost over LIFO cost	(163)	(183)
Total	1,679	1,909
LIFO
Inventory
Raw materials	93	100
Work in process	114	110
Finished goods	430	525
Supplies and other	0	0
Gross inventories	637	735
Excess of FIFO or weighted-average cost over LIFO cost	(163)	(183)
Total	474	552
Non- LIFO
Inventory
Raw materials	236	297
Work in process	89	93
Finished goods	600	689
Supplies and other	280	278
Gross inventories	1,205	1,357
Excess of FIFO or weighted-average cost over LIFO cost	0	0
Total	$ 1,205	$ 1,357

Supplemental Data (Summary of P

Supplemental Data (Summary of Property, Plant and Equipment, Net) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Supplemental Data
Land	$ 163	$ 164
Buildings	2,612	2,537
Machinery and equipment	13,591	13,393
Construction in progress	488	453
Total before accumulated depreciation	16,854	16,547
Less accumulated depreciation	(9,685)	(9,443)
Total	$ 7,169	$ 7,104

Supplemental Data (Summary of92

Supplemental Data (Summary of Accrued Expenses) (Details) - USD ($) $ in Millions	Dec. 31, 2016	Dec. 31, 2015
Supplemental Data
Accrued advertising and promotion	$ 373	$ 339
Accrued salaries and wages	426	392
Accrued rebates	220	229
Accrued taxes - income and other	259	329
Accrued interest	96	82
Derivatives	44	36
Other	357	343
Total	$ 1,775	$ 1,750

Supplemental Data (Summary of C

Supplemental Data (Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accounts receivable	$ (23)	$ 60	$ 267
Inventories	230	(28)	12
Trade accounts payable	(61)	44	(30)
Accrued expenses	26	(110)	(120)
Accrued income taxes	121	(81)	(159)
Derivatives	43	(63)	103
Currency and other	(2)	(267)	(249)
Total	$ 334	$ (445)	$ (176)

Supplemental Data (Other Cash F

Supplemental Data (Other Cash Flow Data and Interest Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Supplemental Data
Interest paid	$ 315	$ 308	$ 300
Income taxes paid	$ 744	$ 695	$ 926

Valuation and Qualifying Acco95

Valuation and Qualifying Accounts (Schedule of Valuation and Qualifying Accounts) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2013	Dec. 31, 2012
Allowance for Doubtful Accounts [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period			$ 50	$ 51
Charged to Costs and Expenses		$ 8	12	13
Charged to Other Accounts	[1]	3	(10)	(7)
Deductions	[2]	11	2	7
Balance at End of Period		50	50	50
Allowances for Sales Discounts [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period			16	20
Charged to Costs and Expenses		254	256	265
Charged to Other Accounts	[1]	0	(1)	(1)
Deductions	[3]	251	256	268
Balance at End of Period		18	15	16
Deferred Taxes [Member]
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period			215	197
Charged to Costs and Expenses		(45)	78	30
Charged to Other Accounts		0	0	0
Deductions	[4]	4	19	12
Balance at End of Period		$ 225	$ 274	$ 215
[1]	Includes bad debt recoveries and the effects of changes in foreign currency exchange rates.
[2]	Primarily uncollectible receivables written off.
[3]	Sales discounts allowed.
[4]	Represents the net currency effects of translating valuation allowances at current rates of exchange.